New DPCO Price List released - March 2019

DPCO PRICE LIST MARCH 2019

Sl No	Medicines	Dosage form and Strength	Unit	Ceiling price (wef 1.4.2019 with WPI @ 4.2662%)	Existing S.O. No. & Date
(1)	(2)	(3)	(4)	(5)	6(a)	6(b)
1	5-aminosalicylic Acid	Suppository 500 mg Retention Enema	1 Suppository	16.55	1461(E)	02.04.2018
2	5-aminosalicylic Acid	Tablet 400 mg	1 Tablet	7.31	1461(E)	02.04.2018
3	5-Fluorouracil	Injection 250 mg/5 ml	1 ml	2.29	1461(E)	02.04.2018
4	6-Mercaptopurine	Tablet 50mg	1 Tablet	6.32	1461(E)	02.04.2018
5	Abacavir	Tablet 300 mg	1 Tablet	46.15	1461(E)	02.04.2018
6	Abacavir (A) + Lamivudine (B)	Tablet 60 mg(A) + 30 mg(B)	1 Tablet	19.65	1461(E)	02.04.2018
7	Abacavir (A) + Lamivudine (B)	Tablet 600 mg(A)+ 300 mg(B)	1 Tablet	89.18	1461(E)	02.04.2018
8	Acetazolamide	Capsule 250 mg	1 Capsule	4.43	1461(E)	02.04.2018
9	Acetazolamide	Tablet 250 mg	1 Tablet	3.58	1461(E)	02.04.2018
10	Acetylsalicylic acid	Effervescent/ Dispersible/ Enteric coated Tablet 100 mg	1 Tablet	0.18	1461(E)	02.04.2018
11	Acetylsalicylic acid	Effervescent/ Dispersible/ Enteric coated Tablet 150 mg	1 Tablet	1.18	1461(E)	02.04.2018
12	Acetylsalicylic acid	Effervescent/ Dispersible/ Enteric coated Tablet 75 mg	1 Tablet	1.20	1461(E)	02.04.2018
13	Acetylsalicylic acid	Tablet 100 mg	1 Tablet	0.17	1461(E)	02.04.2018
14	Acetylsalicylic acid	Tablet 150 mg	1 Tablet	0.40	1461(E)	02.04.2018
15	Acetylsalicylic acid	Tablet 325mg	1 Tablet	0.54	1461(E)	02.04.2018
16	Acetylsalicylic acid	Tablet 350mg	1 Tablet	0.30	1461(E)	02.04.2018
17	Acetylsalicylic acid	Tablet 75 mg	1 Tablet	0.30	1461(E)	02.04.2018
18	Actinomycin D	Powder for Injection	Each Pack	310.35	1461(E)	02.04.2018

		0.5mg
19	Acyclovir	Ointment 3%	1 gm	10.19	1461(E)	02.04.2018
20	Acyclovir	Oral Liquid 400 mg/5ml	1 ml	1.24	1461(E)	02.04.2018
21	Acyclovir	Tablet 200 mg	1 Tablet	6.63	1461(E)	02.04.2018
22	Acyclovir	Tablet 400 mg	1 Tablet	12.04	1461(E)	02.04.2018
23	Acyclovir	Powder for Injection 250 mg	Each Pack	347.72	1461(E)	02.04.2018
24	Acyclovir	Powder for Injection 500 mg	Each Pack	449.12	1461(E)	02.04.2018
25	Adenosine	Injection 3mg/ml	1 ml	96.35	1461(E)	02.04.2018
26	Adrenaline	Injection 1 mg/ml	1 ml	15.32	1461(E)	02.04.2018
27	Albendazole	Oral Liquid 200 mg/5ml	1 ml	1.56	1461(E)	02.04.2018
28	Albendazole	Tablet 400 mg	1 Tablet	7.54	1461(E)	02.04.2018
29	Allopurinol	Tablet 100 mg	1 Tablet	1.86	1461(E)	02.04.2018
30	Allopurinol	Tablet 300 mg	1 Tablet	7.32	1461(E)	02.04.2018
31	Alprostadil	Injection 0.5 mg/ml	1 ml	5542.19	1461(E)	02.04.2018
32	Alteplase	Powder for Injection 20 mg	Each Pack	18588.12	1461(E)	02.04.2018
33	Alteplase	Powder for Injection 50 mg	Each Pack	38810.18	1461(E)	02.04.2018
34	Amiodarone	Injection 50 mg/ml	1 ml	21.83	3983(E)	13.08.2018
35	Amiodarone	Tablet 100 mg	1 Tablet	5.59	1461(E)	02.04.2018
36	Amiodarone	Tablet 200 mg	1 Tablet	11.08	1461(E)	02.04.2018
37	Amitriptyline	Tablet 10 mg	1 Tablet	2.24	1461(E)	02.04.2018
38	Amitriptyline	Tablet 25 mg	1 Tablet	2.21	1461(E)	02.04.2018
39	Amitriptyline	Tablet 50 mg	1 Tablet	5.68	1461(E)	02.04.2018
40	Amitriptyline	Tablet 75 mg	1 Tablet	5.49	1461(E)	02.04.2018
41	Amlodipine	Tablet 10 mg	1 Tablet	4.96	1461(E)	02.04.2018
42	Amlodipine	Tablet 2.5 mg	1 Tablet	1.62	1461(E)	02.04.2018
43	Amlodipine	Tablet 5mg	1 Tablet	2.55	1461(E)	02.04.2018
44	Amoxicillin	Capsule 250 mg	1 Capsule	2.16	1461(E)	02.04.2018
45	Amoxicillin	Oral Liquid 250 mg/5ml	1 ml	1.32	1461(E)	02.04.2018
46	Amoxicillin	Capsule 500mg	1 Capsule	6.32	1461(E)	02.04.2018
47	Amoxicillin (A) + Clavulanic acid (B)	Dry Syrup 125 mg(A) + 31.25 (B)/5 ml	1 ml	2.12	1461(E)	02.04.2018
48	Amoxicillin (A) + Clavulanic acid (B)	Oral Liquid 200 mg(A) + 28.5 mg(B)/5ml	1 ml	1.77	1461(E)	02.04.2018
49	Amoxicillin (A) + Clavulanic acid (B)	Powder for Injection 500 mg(A) + 100 mg(B)	Each Pack	88.10	1461(E)	02.04.2018
50	Amoxicillin (A) +Clavulanic acid (B)	Tablet 500mg(A) +125mg(B)	1 Tablet	17.58	1461(E)	02.04.2018
51	Amoxicillin (A) +Clavulanic acid (B)	Powder for Injection 1g (A) +200mg(B)	Each Pack	122.90	1461(E)	02.04.2018
52	Amphotericin B - Lipid/ Liposomal	Powder for Injection 50 mg	Each Pack	4008.86	3983(E)	13.08.2018
53	Amphotericin B – Conventional	Powder for Injection 50 mg	Each Pack	303.11	1461(E)	02.04.2018
54	Ampicillin	Powder for Injection 1 gm	Each Pack	20.89	1461(E)	02.04.2018
55	Ampicillin	Powder for Injection 500 mg	Each Pack	12.87	1461(E)	02.04.2018
56	Anti-D immunoglobulin	Injection 300mcg	Each Pack	2088.88	1461(E)	02.04.2018
57	Anti-D Immunoglobulin	Injection 150mcg	Each Vial	1628.21	1461(E)	02.04.2018
58	Anti-rabies immunoglobulin	Injection 150 IU/ml	1 ml	2715.04	1461(E)	02.04.2018
59	Anti-rabies immunoglobulin	Injection 300 IU/ml	1 ml	95.72	1461(E)	02.04.2018

60	Anti-tetanus immunoglobulin	250IU	Each Pack	1087.55	5636(E)	02.11.2018
61	Arsenic Trioxide	Injection 1mg/ml	1 ml	53.14	1461(E)	02.04.2018
62	Artemether (A) + Lumefantrine (B)	Oral Liquid 80 mg(A) +480 mg(B) /5ml	1 ml	3.95	1461(E)	02.04.2018
63	Artemether (A) + Lumefantrine (B)	Tablet 20 mg(A) + 120 mg(B)	1 Tablet	12.25	1461(E)	02.04.2018
64	Artemether (A) + Lumefantrine (B)	Tablet 40 mg(A) + 240 mg(B)	1 Tablet	15.79	1461(E)	02.04.2018
65	Artemether (A) + Lumefantrine (B)	Tablet 80 mg(A) + 480 mg(B)	1 Tablet	22.67	1461(E)	02.04.2018
66	Artesunate	Powder for Injection 120 mg	Each Pack	407.23	1461(E)	02.04.2018
67	Artesunate	Powder for Injection 60 mg	Each Pack	213.90	1461(E)	02.04.2018
68	Artesunate (A) + Sulphadoxine - Pyrimethamine (B)	Tablet 100 mg(A) + 1 Tablet (750 mg+ 37.5 mg) (B)	Combi pack	28.87	1461(E)	02.04.2018
69	Artesunate (A) + Sulphadoxine - Pyrimethamine (B)	Tablet 150 mg(A) + 2 Tablet (500 mg+ 25 mg) (B)	Combi pack	39.19	1461(E)	02.04.2018
70	Artesunate (A) + Sulphadoxine - Pyrimethamine (B)	Tablet 200 mg(A) + 2 Tablet (750 mg+ 37.5 mg) (B)	Combi pack	35.73	1461(E)	02.04.2018
71	Artesunate (A) + Sulphadoxine - Pyrimethamine (B)	Tablet 25 mg(A) + 1 Tablet (250 mg+ 12.5 mg) (B)	Combi pack	19.24	1461(E)	02.04.2018
72	Artesunate (A) + Sulphadoxine - Pyrimethamine (B)	1 Tablet 50 mg(A) + 1 Tablet (500 mg+ 25 mg) (B)	Combi Pack	20.77	1461(E)	02.04.2018
73	Ascorbic Acid (Vitamin C)	Tablet 100mg	1 Tablet	0.19	1461(E)	02.04.2018
74	Ascorbic Acid (Vitamin C)	Tablet 500 mg	1 Tablet	0.89	1461(E)	02.04.2018
75	Atazanavir (A) + Ritonavir (B)	Tablet 300 mg(A) + 100 mg(B)	1 Tablet	96.61	1461(E)	02.04.2018
76	Atenolol	Tablet 100 mg	1 Tablet	3.41	1461(E)	02.04.2018
77	Atenolol	Tablet 50 mg	1 Tablet	1.75	1461(E)	02.04.2018
78	Atorvastatin	Tablet 10 mg	1 Tablet	5.37	1461(E)	02.04.2018
79	Atorvastatin	Tablet 20 mg	1 Tablet	13.00	1461(E)	02.04.2018
80	Atorvastatin	Tablet 40 mg	1 Tablet	18.88	1461(E)	02.04.2018
81	Atracurium	Injection 10 mg/ml	Each Pack	51.30	1461(E)	02.04.2018
82	Atropine	Ointment 1%	1 gm	3.70	1461(E)	02.04.2018
83	Atropine	Injection 0.6 mg/ml	1 ml	4.10	1461(E)	02.04.2018
84	Atropine	Drops 1%	1 ml	3.36	1461(E)	02.04.2018
85	Azathioprine	Tablet 50 mg	1 Tablet	9.93	1461(E)	02.04.2018
86	Azithromycin	Capsule 250 mg	1 Capsule	10.28	1461(E)	02.04.2018
87	Azithromycin	Capsule 500 mg	1 Capsule	16.22	1461(E)	02.04.2018
88	Azithromycin	Oral Liquid 200 mg/5ml	1 ml	3.01	1461(E)	02.04.2018
89	Azithromycin	Tablet 250mg	1 Tablet	10.33	1461(E)	02.04.2018
90	Azithromycin	Tablet 500mg	1 Tablet	20.84	1461(E)	02.04.2018
91	Azithromycin	Powder for Injection 500mg	Each Pack	188.15	1461(E)	02.04.2018
92	Baclofen	Tablet 10 mg	1 Tablet	10.52	1461(E)	02.04.2018
93	Baclofen	Tablet 20 mg	1 Tablet	14.48	1461(E)	02.04.2018
94	Baclofen	Tablet 5 mg	1 Tablet	5.42	1461(E)	02.04.2018
95	BCG vaccine		Each Dose	5.83	1769(E)	26.04.2018
96	Benzathine benzylpenicillin	Powder for Injection 12 lac units	Each Pack	11.89	1461(E)	02.04.2018
97	Benzathine benzylpenicillin	Powder for Injection 6 lac units	Each Pack	7.87	1461(E)	02.04.2018
98	Benzoyl Peroxide	Cream 2.5%	1 gm	2.29	1461(E)	02.04.2018

99	Benzoyl Peroxide	Gel 2.5%	1 gm	3.67	1461(E)	02.04.2018
100	Benzyl penicillin	Powder for Injection 10 Lac Units	Each Pack	5.09	1461(E)	02.04.2018
101	Betamethasone	Cream 0.05%	1 gm	0.57	1461(E)	02.04.2018
102	Betamethasone	Cream 0.1%	1 gm	0.82	1461(E)	02.04.2018
103	Betamethasone	Gel 0.05%	1 gm	0.52	1461(E)	02.04.2018
104	Betamethasone	Lotion 0.1%	1 ml	0.80	1461(E)	02.04.2018
105	Betamethasone	Lotion 0.5%	1 ml	0.52	1461(E)	02.04.2018
106	Betamethasone	Injection 4 mg/ml	1 ml	4.11	1461(E)	02.04.2018
107	Bicalutamide	Tablet 50 mg	1 Tablet	67.14	1461(E)	02.04.2018
108	Bisacodyl	Suppository 5 mg	1 Suppository	8.25	1461(E)	02.04.2018
109	Bisacodyl	Tablet 5 mg	1 Tablet	0.98	1461(E)	02.04.2018
110	Bleomycin	Powder for Injection 15 Units	Each Pack	607.49	1461(E)	02.04.2018
111	Bortezomib	Powder for Injection 2 mg	Each Pack	12036.26	1461(E)	02.04.2018
112	Budesonide	Nasal Spray 100 mcg/dose	1 Dose	0.89	1461(E)	02.04.2018
113	Budesonide	Nasal Spray 50 mcg/dose	1 Dose	0.99	1461(E)	02.04.2018
114	Budesonide	Respiratory Solution for use in Nebulizer 0.5 mg/ml	1 ml	10.48	1461(E)	02.04.2018
115	Budesonide	Respiratory Solution for use in Nebulizer 1 mg/ml	1 ml	12.64	1461(E)	02.04.2018
116	Budesonide	Inhalation (MDI) 100 mcg/dose	Per Metered Dose	1.24	1028(E)	26.02.2019
117	Budesonide	Inhalation (MDI) 200 mcg/dose	Per metered Dose	1.54	1028(E)	26.02.2019
118	Budesonide	Inhalation (DPI) 100 mcg/dose	Per Dose	1.95	1028(E)	26.02.2019
119	Budesonide	Inhalation (DPI) 200 mcg/dose	Per Dose	2.83	1028(E)	26.02.2019
120	Budesonide (A)+ Formoterol (B)	Inhalation (MDI) 100 mcg (A) + 6 mcg (B)	Per Metered Dose	1.85	1028(E)	26.02.2019
121	Budesonide (A)+ Formoterol (B)	Inhalation (MDI) 200 mcg (A) + 6 mcg (B)	Per Metered Dose	2.62	1028(E)	26.02.2019
122	Budesonide (A)+ Formoterol (B)	Inhalation (MDI) 400 mcg (A) + 6 mcg (B)	Per Metered Dose	2.98	1028(E)	26.02.2019
123	Budesonide (A)+ Formoterol (B)	Inhalation (DPI) 100 mcg (A) + 6 mcg (B)	Per Dose	3.71	1028(E)	26.02.2019
124	Budesonide (A)+ Formoterol (B)	Inhalation (DPI) 200 mcg (A) + 6 mcg (B)	Per Dose	4.93	1028(E)	26.02.2019
125	Budesonide (A)+ Formoterol (B)	Inhalation (DPI) 400 mcg (A) + 6 mcg (B)	Per Dose	6.30	1028(E)	26.02.2019
126	Bupivacaine	Injection 0.25%	1 ml	2.40	1461(E)	02.04.2018
127	Bupivacaine	Injection 0.5% with 7.5% glucose	1 ml	6.08	1461(E)	02.04.2018
128	Bupivacaine	Injection 0.50%	1 ml	3.84	1461(E)	02.04.2018
129	Caffeine	Injection 20 mg/ml	1 ml	245.64	1461(E)	02.04.2018
130	Caffeine	Oral Liquid 20 mg/ml	1 ml	208.63	1461(E)	02.04.2018
131	Calamine	Lotion (As per IP)	1 ml	0.83	1461(E)	02.04.2018
132	Calcium folinate	Tablet 15 mg	1 Tablet	39.92	1461(E)	02.04.2018
133	Calcium gluconate	Injection 100 mg/ml	1 ml	0.54	1461(E)	02.04.2018
134	Capecitabine	Tablet 500 mg	1 Tablet	123.68	1461(E)	02.04.2018
135	Capreomycin	Powder for Injection 1 gm	Each Pack	338.98	1461(E)	02.04.2018
136	Carbamazepine	Oral Liquid 100 mg/5ml	1 ml	0.19	1461(E)	02.04.2018

137	Carbamazepine	CR Tablet 200 mg	1 Tablet	1.52	1461(E)	02.04.2018
138	Carbamazepine	CR Tablet 400 mg	1 Tablet	2.99	1461(E)	02.04.2018
139	Carbamazepine	Tablet 100 mg	1 Tablet	0.67	1461(E)	02.04.2018
140	Carbamazepine	Tablet 200 mg	1 Tablet	1.36	1461(E)	02.04.2018
141	Carbamazepine	Tablet 400 mg	1 Tablet	3.23	1461(E)	02.04.2018
142	Carbimazole	Tablet 10 mg	1 Tablet	3.62	1461(E)	02.04.2018
143	Carbimazole	Tablet 5 mg	1 Tablet	1.86	1461(E)	02.04.2018
144	Carboplatin	Injection 10 mg/ml	1 ml	52.08	1461(E)	02.04.2018
145	Carboxymethylcellulose	Drops 0.5%	1 ml	12.50	1461(E)	02.04.2018
146	Carboxymethylcellulose	Drops 1%	1 ml	17.33	1461(E)	02.04.2018
147	Cefadroxil	Capsule 500 mg	1 Capsule	7.00	1461(E)	02.04.2018
148	Cefadroxil	Oral Liquid 125 mg/5ml	1 ml	0.62	1461(E)	02.04.2018
149	Cefadroxil	Tablet 1 gm	1 Tablet	6.15	1461(E)	02.04.2018
150	Cefadroxil	Tablet 500 mg	1 Tablet	3.95	1461(E)	02.04.2018
151	Cefazolin	Powder for Injection 1 gm	Each Pack	24.03	1461(E)	02.04.2018
152	Cefazolin	Powder for Injection 500 mg	Each Pack	15.23	1461(E)	02.04.2018
153	Cefixime	Capsule 200 mg	1 Capsule	14.12	1461(E)	02.04.2018
154	Cefixime	Capsule 400 mg	1 Capsule	28.61	1461(E)	02.04.2018
155	Cefixime	Oral Liquid 100 mg/5ml	1 ml	2.11	1461(E)	02.04.2018
156	Cefixime	Oral Liquid 50 mg/5ml	1 ml	1.42	1461(E)	02.04.2018
157	Cefixime	Tablet 400 mg	1 Tablet	21.59	1461(E)	02.04.2018
158	Cefixime	Tablet 200mg	1 Tablet	9.39	1461(E)	02.04.2018
159	Cefotaxime	Powder for Injection 1 gm	Each Pack	33.59	1461(E)	02.04.2018
160	Cefotaxime	Powder for Injection 250 mg	Each Pack	15.27	1461(E)	02.04.2018
161	Cefotaxime	Powder for Injection 500 mg	Each Pack	20.08	1461(E)	02.04.2018
162	Ceftazidime	Powder for Injection 1 gm	Each Pack	204.82	1461(E)	02.04.2018
163	Ceftazidime	Powder for Injection 250 mg	Each Pack	63.70	1461(E)	02.04.2018
164	Ceftriaxone	Powder for Injection 1gm	Each Pack	52.76	1461(E)	02.04.2018
165	Ceftriaxone	Powder for Injection 2 gm	Each Pack	125.41	1461(E)	02.04.2018
166	Ceftriaxone	Powder for Injection 250 mg	Each Pack	24.15	1461(E)	02.04.2018
167	Ceftriaxone	Powder for Injection 500 mg	Each Pack	44.12	1461(E)	02.04.2018
168	Cetirizine	Capsule 10 mg	1 Capsule	2.33	1461(E)	02.04.2018
169	Cetirizine	Oral Liquid 5 mg/5ml	1 ml	0.58	1461(E)	02.04.2018
170	Cetirizine	Tablet 10 mg	1 Tablet	1.62	1461(E)	02.04.2018
171	Cetrimide	Solution 20% (concentrate for dilution)	1 ml	0.31	1461(E)	02.04.2018
172	Chlorambucil	Tablet 2 mg	1 Tablet	36.12	1461(E)	02.04.2018
173	Chlorambucil	Tablet 5 mg	1 Tablet	81.17	1461(E)	02.04.2018
174	Chlorhexidine	Solution 5% (Concentrate for dilution)	1 ml	0.15	1461(E)	02.04.2018
175	Chloroquine	Oral Liquid 50 mg/5ml	1 ml	0.29	1461(E)	02.04.2018
176	Chloroquine	Tablet 150mg	1 Tablet	0.77	1461(E)	02.04.2018
177	Chlorpheniramine	Tablet 4 mg	1 Tablet	0.09	1461(E)	02.04.2018

178	Cholecalciferol	Capsule 1000 IU	1 Capsule	4.67	1461(E)	02.04.2018
179	Cholecalciferol	Capsule 60000 IU	1 Capsule	28.90	1461(E)	02.04.2018
180	Cholecalciferol	Oral Liquid 400 IU/ml	1 ml	2.30	1461(E)	02.04.2018
181	Cholecalciferol	Tablet 1000 IU	1 Tablet	3.67	1461(E)	02.04.2018
182	Cholecalciferol	Tablet 60000 IU	1 Tablet	23.73	1461(E)	02.04.2018
183	Ciprofloxacin	Ointment 0.3%	1 gm	1.11	1461(E)	02.04.2018
184	Ciprofloxacin	Drops 0.30%	1 ml	1.49	1461(E)	02.04.2018
185	Ciprofloxacin	Injection 200 mg/100ml	1 ml	0.17	1461(E)	02.04.2018
186	Ciprofloxacin	Oral Liquid 250 mg/5ml	1 ml	0.62	1461(E)	02.04.2018
187	Ciprofloxacin	Tablet 250mg	1 Tablet	2.03	1461(E)	02.04.2018
188	Ciprofloxacin	Tablet 500mg	1 Tablet	3.57	1461(E)	02.04.2018
189	Cisplatin	Injection 1 mg/ml	1 ml	6.74	1461(E)	02.04.2018
190	Clarithromycin	Oral Liquid 125 mg/5ml	1 ml	4.22	1461(E)	02.04.2018
191	Clarithromycin	Tablet 250 mg	1 Tablet	27.40	1461(E)	02.04.2018
192	Clarithromycin	Tablet 500 mg	1 Tablet	48.30	1461(E)	02.04.2018
193	Clindamycin	Capsule 150 mg	1 Capsule	14.16	1461(E)	02.04.2018
194	Clindamycin	Capsule 300 mg	1 Capsule	23.12	1461(E)	02.04.2018
195	Clindamycin	Tablet 300 mg	1 Tablet	14.92	1461(E)	02.04.2018
196	Clobazam	Tablet 10 mg	1 Tablet	8.84	1461(E)	02.04.2018
197	Clobazam	Tablet 5 mg	1 Tablet	5.03	1461(E)	02.04.2018
198	Clofazimine	Capsule 100 mg	1 Capsule	2.42	1461(E)	02.04.2018
199	Clofazimine	Capsule 50 mg	1 Capsule	1.42	1461(E)	02.04.2018
200	Clomiphene	Capsule 100 mg	1 Capsule	54.47	1461(E)	02.04.2018
201	Clomiphene	Capsule 50 mg	1 Capsule	29.97	1461(E)	02.04.2018
202	Clomiphene	Tablet 100mg	1 Tablet	11.95	1461(E)	02.04.2018
203	Clomiphene	Tablet 50mg	1 Tablet	8.15	1461(E)	02.04.2018
204	Clomipramine	Tablet 10 mg	1 Tablet	2.46	1461(E)	02.04.2018
205	Clomipramine	Tablet 25 mg	1 Tablet	5.43	1461(E)	02.04.2018
206	Clomipramine	Tablet 75 mg	1 Tablet	14.04	1461(E)	02.04.2018
207	Clonazepam	Tablet 0.25 mg	1 Tablet	1.79	1461(E)	02.04.2018
208	Clonazepam	Tablet 0.5 mg	1 Tablet	3.04	1461(E)	02.04.2018
209	Clonazepam	Tablet 1 mg	1 Tablet	4.14	1461(E)	02.04.2018
210	Clopidogrel	Tablet 75 mg	1 Tablet	6.80	1461(E)	02.04.2018
211	Clotrimazole	Cream 1%	1 gm	2.85	3983(E)	13.08.2018
212	Clotrimazole	Drops 1%	1 ml	2.96	1461(E)	02.04.2018
213	Clotrimazole	Lotion 1%	1 ml	3.50	1461(E)	02.04.2018
214	Clotrimazole	Pessary 100 mg	1 Pessary	8.50	1461(E)	02.04.2018
215	Cloxacillin	Capsule 250mg	1 Capsule	1.11	1461(E)	02.04.2018
216	Cloxacillin	Capsule 500mg	1 Capsule	1.86	1461(E)	02.04.2018
217	Cloxacillin	Tablet 250mg	1 Tablet	1.69	1461(E)	02.04.2018
218	Cloxacillin	Powder for Injection250mg	Each Pack	4.35	1461(E)	02.04.2018
219	Clozapine	Tablet 100 mg	1 Tablet	7.58	1461(E)	02.04.2018
220	Clozapine	Tablet 25 mg	1 Tablet	2.46	1461(E)	02.04.2018
221	Clozapine	Tablet 50 mg	1 Tablet	4.70	1461(E)	02.04.2018
222	Coagulation factor IX	Powder for Injection 600 IU	Each Pack	12057.74	1461(E)	02.04.2018
223	Coagulation factor VIII	Powder for Injection 250 IU	Each pack	3655.22	1461(E)	02.04.2018
224	Coagulation factor VIII	Powder for Injection 500 IU	Each Pack	8969.65	1461(E)	02.04.2018
225	Colchicine	Tablet 0.5 mg	1 Tablet	3.04	1461(E)	02.04.2018
226	Co-trimoxazole (Sulphamethoxazole (A)+Trimethoprim (B)]	Oral Liquid 200 mg(A)+40 mg(B)/5ml	1 ml	0.21	1461(E)	02.04.2018
227	Co-trimoxazole	Tablet 400 mg(A)+80	1 Tablet	0.51	1461(E)	02.04.2018

	(Sulphamethoxazole (A)+Trimethoprim (B)]	mg(B)
228	Co-trimoxazole (Sulphamethoxazole (A)+Trimethoprim (B)]	Tablet 800 mg(A)+160 mg(B)	1 Tablet	1.32	2399(E)	12.06.2018
229	Cyclophosphamide	Tablet 50 mg	1 Tablet	3.97	1461(E)	02.04.2018
230	Cyclophosphamide	Powder for Injection 500 mg	Each Pack	78.11	1461(E)	02.04.2018
231	Cycloserine	Capsule 250 mg	1 Capsule	53.13	1461(E)	02.04.2018
232	Cycloserine	Tablet 250 mg	1 Tablet	45.68	1461(E)	02.04.2018
233	Cyclosporine	Capsule 100 mg	1 Capsule	100.31	1461(E)	02.04.2018
234	Cyclosporine	Capsule 25 mg	1 Capsule	26.92	1461(E)	02.04.2018
235	Cyclosporine	Capsule 50 mg	1 Capsule	51.52	1461(E)	02.04.2018
236	Cyclosporine	Injection 50 mg/ml	1 ml	263.96	1461(E)	02.04.2018
237	Cyclosporine	Oral Liquid 100 mg/ml	1 ml	92.50	1461(E)	02.04.2018
238	Cytosine arabinoside	Injection 100 mg/ml	Each Pack	194.43	1461(E)	02.04.2018
239	Cytosine arabinoside	Powder for Injection 1000 mg	Each Pack	1048.65	1461(E)	02.04.2018
240	Cytosine arabinoside	Powder for Injection 500 mg	Each Pack	501.20	1461(E)	02.04.2018
241	Dacarbazine	Powder for Injection 200 mg	Each Pack	429.93	1461(E)	02.04.2018
242	Dacarbazine	Powder for Injection 500 mg	Each Pack	969.87	1461(E)	02.04.2018
243	Dapsone	Tablet 100 mg	1 Tablet	0.23	1461(E)	02.04.2018
244	Darunavir	Tablet 600 mg	1 Tablet	163.35	1461(E)	02.04.2018
245	Desferrioxamine	Powder for Injection 500mg	Each pack	157.37	1461(E)	02.04.2018
246	Dexamethasone	Tablet 0.5 mg	1 Tablet	0.19	1461(E)	02.04.2018
247	Dexamethasone	Injection 4 mg/ml	Each Pack (10 ml)	13.48	1461(E)	02.04.2018
248	Dexamethasone	Injection 4 mg/ml	Each Pack (2 ml)	9.12	1028(E)	26.02.2019
249	Dexamethasone	Injection 4 mg/ml	Each Pack (20 ml)	25.83	1461(E)	02.04.2018
250	Dexamethasone	Injection 4 mg/ml	Each Pack (30 ml)	34.52	1461(E)	02.04.2018
251	Dextran-40	Injection 10%	1 ml	0.83	3983(E)	13.08.2018
252	Diazepam	Injection 5 mg/ml	1 ml	5.93	1461(E)	02.04.2018
253	Diazepam	Oral Liquid 2 mg/5ml	1 ml	2.68	1461(E)	02.04.2018
254	Diazepam	Suppository 5 mg	1 Suppository	5.85	1461(E)	02.04.2018
255	Diazepam	Tablet 2 mg	1 Tablet	1.47	1461(E)	02.04.2018
256	Diazepam	Tablet 5 mg	1 Tablet	1.39	1461(E)	02.04.2018
257	Diclofenac	Capsule 50 mg	1 Capsule	0.60	1461(E)	02.04.2018
258	Diclofenac	Injection 25 mg/ml	1 ml	1.43	1461(E)	02.04.2018
259	Diclofenac	Tablet 50 mg	1 Tablet	1.87	1461(E)	02.04.2018
260	Dicyclomine	Injection 10 mg/ml (10ml & 30ml Pack)	1 ml	2.01	1461(E)	02.04.2018
261	Dicyclomine	Injection 10 mg/ml (1ml & 2ml Pack)	1 ml	3.12	1461(E)	02.04.2018
262	Dicyclomine	Oral Solution 10mg/5ml	1 ml	0.16	1461(E)	02.04.2018
263	Dicyclomine	Tablet 10mg	1 Tablet	0.11	1461(E)	02.04.2018
264	Diethylcarbamazine	Oral Liquid 120 mg/5ml	1 ml	0.48	1461(E)	02.04.2018
265	Diethylcarbamazine	Tablet 100 mg	1 Tablet	1.38	1461(E)	02.04.2018
266	Diethylcarbamazine	Tablet 50 mg	1 Tablet	0.55	1461(E)	02.04.2018
267	Digoxin	Injection 0.25 mg/ml	1 ml	3.26	1461(E)	02.04.2018
268	Digoxin	Oral liquid 0.05	1 ml	1.24	3241(E)	04.07.2018

		mg/ml
269	Digoxin	Tablet 0.25 mg	1 Tablet	1.17	1461(E)	02.04.2018
270	Diloxanide furoate	Tablet 500mg	1 Tablet	1.03	1461(E)	02.04.2018
271	Diltiazem	Capsule 90 mg	1 Capsule	9.40	1461(E)	02.04.2018
272	Diltiazem	Injection 5 mg/ml	1 ml	3.09	1461(E)	02.04.2018
273	Diltiazem	SR Tablet 90 mg	1 Tablet	9.13	1461(E)	02.04.2018
274	Diltiazem	Tablet 30 mg	1 Tablet	2.35	1461(E)	02.04.2018
275	Diltiazem	Tablet 60 mg	1 Tablet	4.78	1461(E)	02.04.2018
276	Dimercaprol	Injection 50 mg/ml	1 ml	195.86	5633(E)	02.11.2018
277	Dinoprostone	Gel 0.5 mg	1 gm	79.33	1461(E)	02.04.2018
278	Dinoprostone	Tablet 0.5mg	1 Tablet	48.98	1461(E)	02.04.2018
279	Diphtheria antitoxin	10000 IU	Each Pack	1282.59	1461(E)	02.04.2018
280	Dobutamine	Injection 50 mg/ml	Each Pack	36.70	1461(E)	02.04.2018
281	Docetaxel	Powder for Injection 20 mg	Each Pack	2929.38	1461(E)	02.04.2018
282	Docetaxel	Powder for Injection 80 mg	Each Pack	11137.71	1461(E)	02.04.2018
283	Domperidone	Oral Liquid 1 mg/ml	1 ml	1.05	1461(E)	02.04.2018
284	Domperidone	Tablet 10 mg	1 Tablet	2.37	1461(E)	02.04.2018
285	Donepezil	Tablet 10 mg	1 Tablet	15.70	1461(E)	02.04.2018
286	Donepezil	Tablet 5 mg	1 Tablet	11.00	1461(E)	02.04.2018
287	Dopamine	Injection 40 mg/ml	1 ml	5.53	1461(E)	02.04.2018
288	Doxorubicin	Injection 2 mg/ml	1 ml	35.14	1461(E)	02.04.2018
289	Doxycycline	Capsule 100 mg	1 Capsule	2.45	1461(E)	02.04.2018
290	Doxycycline	Tablet 100 mg	1 Tablet	0.95	1461(E)	02.04.2018
291	DPT + Hib + Hep B vaccine		Per 0.1 ml	78.60	1461(E)	02.04.2018
292	DPT vaccine		Per 0.5 ml	13.86	1461(E)	02.04.2018
293	Efavirenz	Capsule 200 mg	1 Capsule	23.56	1461(E)	02.04.2018
294	Efavirenz	Capsule 600 mg	1 Capsule	61.38	1461(E)	02.04.2018
295	Efavirenz	Tablet 200 mg	1 Tablet	22.19	1461(E)	02.04.2018
296	Efavirenz	Tablet 600 mg	1 Tablet	69.50	1461(E)	02.04.2018
297	Enalapril	Tablet 2.5 mg	1 Tablet	1.89	1461(E)	02.04.2018
298	Enalapril	Tablet 5 mg	1 Tablet	3.14	1461(E)	02.04.2018
299	Enoxaparin	Injection 40 mg/0.4ml	0.1 ml	99.48	1461(E)	02.04.2018
300	Enoxaparin	Injection 60 mg/0.6ml	0.1 ml	99.48	1461(E)	02.04.2018
301	Entecavir	Tablet 0.5 mg	1 Tablet	78.08	1461(E)	02.04.2018
302	Entecavir	Tablet 1 mg	1 Tablet	124.06	1461(E)	02.04.2018
303	Erythropoietin	Injection 10000 IU/ml	Each pack	2545.89	1461(E)	02.04.2018
304	Erythropoietin	Injection 2000 IU/ml	Each pack	603.00	1461(E)	02.04.2018
305	Escitalopram	Tablet 10 mg	1 Tablet	7.93	1461(E)	02.04.2018
306	Escitalopram	Tablet 20 mg	1 Tablet	12.52	1461(E)	02.04.2018
307	Escitalopram	Tablet 5 mg	1 Tablet	4.47	1461(E)	02.04.2018
308	Esmolol	Injection 10mg/ml	1 ml	21.20	1461(E)	02.04.2018
309	Ethambutol	Tablet 200 mg	1 Tablet	1.03	1461(E)	02.04.2018
310	Ethambutol	Tablet 400 mg	1 Tablet	2.35	1461(E)	02.04.2018
311	Ethambutol	Tablet 600 mg	1 Tablet	3.46	1461(E)	02.04.2018
312	Ethambutol	Tablet 800 mg	1 Tablet	4.14	1461(E)	02.04.2018
313	Ethinylestradiol	Tablet 0.01 mg	1 Tablet	2.30	1461(E)	02.04.2018
314	Ethinylestradiol	Tablet 0.05 mg	1 Tablet	3.67	1461(E)	02.04.2018
315	Ethinylestradiol (A) + Levonorgestrel (B)	Tablet 0.03 mg(A) + 0.15 mg(B)	1 Tablet	3.38	1461(E)	02.04.2018
316	Ethionamide	Tablet 250 mg	1 Tablet	15.45	1461(E)	02.04.2018
317	Etoposide	Capsule 50 mg	1 Capsule	53.21	1461(E)	02.04.2018
318	Etoposide	Injection 20 mg/ml	1 ml	35.09	1461(E)	02.04.2018
319	Fentanyl	Injection 50mcg/ml	1 ml	22.22	1461(E)	02.04.2018

320	Filgrastim	Injection 300 mcg	Each pack	1342.98	1461(E)	02.04.2018
321	Fluconazole	Capsule 100 mg	1 Capsule	24.72	1461(E)	02.04.2018
322	Fluconazole	Capsule 150 mg	1 Capsule	18.15	1461(E)	02.04.2018
323	Fluconazole	Capsule 200 mg	1 Capsule	35.73	1461(E)	02.04.2018
324	Fluconazole	Oral Liquid 50mg/5ml	1 ml	2.56	1461(E)	02.04.2018
325	Fluconazole	Tablet 100 mg	1 Tablet	7.81	1461(E)	02.04.2018
326	Fluconazole	Tablet 150 mg	1 Tablet	11.59	1461(E)	02.04.2018
327	Fluconazole	Tablet 200 mg	1 Tablet	18.38	1461(E)	02.04.2018
328	Fluconazole	Tablet 400 mg	1 Tablet	30.57	1461(E)	02.04.2018
329	Fluconazole	Injection 200 mg/100 ml	Each Pack	104.15	1461(E)	02.04.2018
330	Flunarizine	Tablet 10 mg	1 Tablet	4.63	1461(E)	02.04.2018
331	Flunarizine	Tablet 5 mg	1 Tablet	2.70	1461(E)	02.04.2018
332	Fluoxetine	Capsule 10 mg	1 Capsule	2.91	1461(E)	02.04.2018
333	Fluoxetine	Capsule 20 mg	1 Capsule	3.57	1461(E)	02.04.2018
334	Fluoxetine	Capsule 40 mg	1 Capsule	5.42	1461(E)	02.04.2018
335	Fluoxetine	Capsule 60 mg	1 Capsule	9.58	1461(E)	02.04.2018
336	Fluoxetine	Tablet 10 mg	1 Tablet	2.44	1461(E)	02.04.2018
337	Fluoxetine	Tablet 20 mg	1 Tablet	3.88	1461(E)	02.04.2018
338	Fluoxetine	Tablet 40 mg	1 Tablet	5.22	1461(E)	02.04.2018
339	Fluoxetine	Tablet 60 mg	1 Tablet	7.24	1461(E)	02.04.2018
340	Fluphenazine	Depot Injection 25 mg/ml	1 ml	48.96	1461(E)	02.04.2018
341	Folic Acid	Capsule 5 mg	1 Capsule	5.52	1461(E)	02.04.2018
342	Folic Acid	Tablet 5 mg	1 Tablet	1.36	1461(E)	02.04.2018
343	Furosemide	Oral liquid 10 mg/ml	1 ml	2.71	3241(E)	04.07.2018
344	Furosemide	Tablet 40 mg	1 Tablet	0.49	1461(E)	02.04.2018
345	Furosemide	Injection 10mg/ml	1 ml	1.62	1461(E)	02.04.2018
346	Fusidic acid	Cream 2%	1 gm	8.93	1461(E)	02.04.2018
347	Gadobenate	Injection 529 mg/ml	1 ml	106.66	1461(E)	02.04.2018
348	Ganciclovir	Capsule 250 mg	1 Capsule	117.65	1461(E)	02.04.2018
349	Ganciclovir	Powder for Injection 500 mg	Each Pack	1651.52	1461(E)	02.04.2018
350	Gefitinib	Tablet 250 mg	1 Tablet	419.44	1461(E)	02.04.2018
351	Gemcitabine	Powder for Injection 1 gm	Each Pack	5191.88	1461(E)	02.04.2018
352	Gemcitabine	Powder for Injection 200mg	Each Pack	1146.62	1461(E)	02.04.2018
353	Gentamicin	Drops 0.3%	1 ml	0.89	1461(E)	02.04.2018
354	Gentamicin	Injection 10 mg/ml	1 ml	3.11	1461(E)	02.04.2018
355	Gentamicin	Injection 40 mg/ml	Each Pack (10 ml)	17.58	1461(E)	02.04.2018
356	Gentamicin	Injection 40 mg/ml	Each Pack (2 ml)	8.23	1028(E)	26.02.2019
357	Gentamicin	Injection 40 mg/ml	Each Pack (20 ml)	26.65	1461(E)	02.04.2018
358	Gentamicin	Injection 40 mg/ml	Each Pack (30 ml)	29.17	1461(E)	02.04.2018
359	Glimepiride	Tablet 1 mg	1 Tablet	3.51	1461(E)	02.04.2018
360	Glimepiride	Tablet 2 mg	1 Tablet	5.58	1461(E)	02.04.2018
361	Glucose	Injection 25%	1 ml	0.17	1461(E)	02.04.2018
362	Glucose	Injection 50%	1 ml	0.48	1461(E)	02.04.2018
363	Glucose	Injection 5%	1000ml Glass	62.86	1461(E)	02.04.2018
364	Glucose	Injection 5%	1000ml Non- Glass	50.73	1461(E)	02.04.2018
365	Glucose	Injection 5%	100ml Glass	17.64	1461(E)	02.04.2018
366	Glucose	Injection 5%	100ml Non- Glass	15.97	1461(E)	02.04.2018

367	Glucose	Injection 5%	250ml Glass	24.38	1461(E)	02.04.2018
368	Glucose	Injection 5%	250ml Non- Glass	22.02	1461(E)	02.04.2018
369	Glucose	Injection 5%	500ml Glass	34.60	1461(E)	02.04.2018
370	Glucose	Injection 5%	500ml Non- Glass	29.86	1461(E)	02.04.2018
371	Glucose	Injection 10%	Each Pack (1000 ml)	25.27	1461(E)	02.04.2018
372	Glucose	Injection 10%	Each Pack (500 ml)	27.49	1461(E)	02.04.2018
373	Glucose (A) + Sodium Chloride (B)	Injection 5% (A) + 0.9% (B)	1000ml Glass	63.26	1461(E)	02.04.2018
374	Glucose (A) + Sodium Chloride (B)	Injection 5% (A) + 0.9% (B)	1000ml Non- Glass	51.12	1461(E)	02.04.2018
375	Glucose (A) + Sodium Chloride (B)	Injection 5% (A) + 0.9% (B)	100ml Glass	17.69	1461(E)	02.04.2018
376	Glucose (A) + Sodium Chloride (B)	Injection 5% (A) + 0.9% (B)	100ml Non- Glass	15.99	1461(E)	02.04.2018
377	Glucose (A) + Sodium Chloride (B)	Injection 5% (A) + 0.9% (B)	250ml Glass	24.48	1461(E)	02.04.2018
378	Glucose (A) + Sodium Chloride (B)	Injection 5% (A) + 0.9% (B)	250ml Non- Glass	22.10	1461(E)	02.04.2018
379	Glucose (A) + Sodium Chloride (B)	Injection 5% (A) + 0.9% (B)	500ml Glass	34.77	1461(E)	02.04.2018
380	Glucose (A) + Sodium Chloride (B)	Injection 5% (A) + 0.9% (B)	500ml Non- Glass	30.04	1461(E)	02.04.2018
381	Glutaraldehyde	Solution 2%	1 ml	0.06	1461(E)	02.04.2018
382	Glycerin	Oral Liquid	1 ml	0.15	1461(E)	02.04.2018
383	Glyceryl Trinitrate	Injection 5 mg/ml	1 ml	6.42	1461(E)	02.04.2018
384	Glyceryl Trinitrate	Sublingual Tablet 0.5 mg	1 Tablet	1.77	1461(E)	02.04.2018
385	Glycopyrrolate	Injection 0.2 mg/ml	1 ml	12.02	1461(E)	02.04.2018
386	Griseofulvin	Tablet 125mg	1 Tablet	0.80	1461(E)	02.04.2018
387	Griseofulvin	Tablet 250 mg	1 Tablet	1.56	1461(E)	02.04.2018
388	Griseofulvin	Tablet 375 mg	1 Tablet	4.21	1461(E)	02.04.2018
389	Haemodialysis fluid	As license	1 ml	0.04	1461(E)	02.04.2018
390	Haloperidol	Injection 5 mg/ml	1 ml	5.70	1461(E)	02.04.2018
391	Haloperidol	Oral Liquid 2 mg/ 5ml	1 ml	2.01	1461(E)	02.04.2018
392	Haloperidol	Tablet 1.5 mg	1 Tablet	1.62	1461(E)	02.04.2018
393	Haloperidol	Tablet 10 mg	1 Tablet	4.32	1461(E)	02.04.2018
394	Haloperidol	Tablet 20 mg	1 Tablet	4.82	1461(E)	02.04.2018
395	Haloperidol	Tablet 5 mg	1 Tablet	3.37	1461(E)	02.04.2018
396	Halothane	Inhalation	1 ml	5.73	1461(E)	02.04.2018
397	Heparin	Injection 1000 IU/ml	1 ml	15.96	1461(E)	02.04.2018
398	Heparin	Injection 5000 IU/ml	1 ml	39.61	1461(E)	02.04.2018
399	Hepatitis B immunoglobulin		Each Pack	5390.60	1461(E)	02.04.2018
400	Hepatitis B vaccine		1 ml	76.64	1461(E)	02.04.2018
401	Homatropine	Drops 2%	1 ml	6.08	1461(E)	02.04.2018
402	Hormone releasing IUD	Contains 52 mgof Levonorgestrel	1 IUD	3785.52	1461(E)	02.04.2018
403	Human chorionic Gonadotropin	Injection 1000 IU	Each Pack	207.98	1461(E)	02.04.2018
404	Human chorionic Gonadotropin	Injection 5000 IU	Each Pack	408.44	1461(E)	02.04.2018
405	Human Normal Immunoglobulin		1 ml	150.97	1461(E)	02.04.2018
406	Hydrochlorothiazide	Tablet 12.5 mg	1 Tablet	0.96	1461(E)	02.04.2018
407	Hydrochlorothiazide	Tablet 25 mg	1 Tablet	1.65	1461(E)	02.04.2018
408	Hydrochlorothiazide	Tablet 50 mg	1 Tablet	0.08	1461(E)	02.04.2018
409	Hydrocortisone	Tablet 10 mg	1 Tablet	5.76	1461(E)	02.04.2018
410	Hydrocortisone	Tablet 5 mg	1 Tablet	2.96	1461(E)	02.04.2018

411	Hydrocortisone	Injection 100 mg	Each Pack	38.08	1461(E)	02.04.2018
412	Hydrocortisone	Injection 200 mg	Each Pack	58.71	1461(E)	02.04.2018
413	Hydrocortisone	Powder for Injection 100 mg	Each Pack	38.08	1461(E)	02.04.2018
414	Hydrogen peroxide	Solution 6%	1 ml	0.04	1461(E)	02.04.2018
415	Hydroxychloroquine	Tablet 200 mg	1 Tablet	5.80	1461(E)	02.04.2018
416	Hydroxychloroquine	Tablet 400 mg	1 Tablet	11.69	1461(E)	02.04.2018
417	Hydroxypropyl methylcellulose	Injection 2%	1 ml	36.70	1461(E)	02.04.2018
418	Hydroxyurea	Capsule 500 mg	1 Capsule	12.54	1461(E)	02.04.2018
419	Hyoscine butylbromide	Injection 20 mg/ml	1 ml	10.21	1461(E)	02.04.2018
420	Hyoscine Butylbromide	Tablet 10 mg	1 Tablet	2.91	1461(E)	02.04.2018
421	Ibuprofen	Capsule 400 mg	1 Capsule	1.03	1461(E)	02.04.2018
422	Ibuprofen	Tablet 200 mg	1 Tablet	0.38	1461(E)	02.04.2018
423	Ibuprofen	Tablet 400 mg	1 Tablet	0.68	1461(E)	02.04.2018
424	Ibuprofen	Oral Liquid 100mg/5ml	1 ml	0.19	1461(E)	02.04.2018
425	Ifosfamide	Powder for Injection 1g	Each Pack	354.11	1461(E)	02.04.2018
426	Ifosfamide	Powder for Injection 2g	Each Pack	929.49	1461(E)	02.04.2018
427	Imatinib	Capsule 100 mg	1 Capsule	75.97	1461(E)	02.04.2018
428	Imatinib	Capsule 400 mg	1 Capsule	249.96	1461(E)	02.04.2018
429	Imatinib	Tablet 100 mg	1 Tablet	77.73	1461(E)	02.04.2018
430	Imatinib	Tablet 400 mg	1 Tablet	225.00	1461(E)	02.04.2018
431	Insulin (Soluble)	Injection 40 IU/ml	1 ml	14.73	1461(E)	02.04.2018
432	Intermediate Acting (NPH) Insulin	Injection 40 IU/ml	1 ml	14.73	1461(E)	02.04.2018
433	Iohexol	Injection 300mgiodine/ml	1 ml	16.27	1461(E)	02.04.2018
434	Ipratropium	Inhalation (MDI/DPI) 20 mcg/dose	1 Dose	0.60	1461(E)	02.04.2018
435	Ipratropium	Respirator solution for use in Nebulizer 250 mcg/ml	1 ml	2.48	1461(E)	02.04.2018
436	Iron sucrose	Injection 20 mg/ml	1 ml	52.60	1461(E)	02.04.2018
437	Isoflurane	Inhalation	1 ml	10.23	1461(E)	02.04.2018
438	Isoniazid	Tablet 100mg	1 Tablet	0.67	1461(E)	02.04.2018
439	Isoniazid	Tablet 300mg	1 Tablet	1.17	1461(E)	02.04.2018
440	Isosorbide 5 Mononitrate	Tablet 20 mg	1 Tablet	3.21	1461(E)	02.04.2018
441	Isosorbide dinitrate	Tablet 10 mg	1 Tablet	0.72	1461(E)	02.04.2018
442	Isosorbide dinitrate	Tablet 5 mg	1 Tablet	0.74	1461(E)	02.04.2018
443	Isosorbide-5-mononitrate	SR Capsule 30 mg	1 Capsule	3.43	1461(E)	02.04.2018
444	Isosorbide-5-mononitrate	SR Capsule 60 mg	1 Capsule	3.41	1461(E)	02.04.2018
445	Isosorbide-5-mononitrate	SR Tablet 30 mg	1 Tablet	4.79	1461(E)	02.04.2018
446	Isosorbide-5-mononitrate	SR Tablet 60 mg	1 Tablet	6.25	1461(E)	02.04.2018
447	Isosorbide-5-mononitrate	Tablet 10 mg	1 Tablet	1.92	1461(E)	02.04.2018
448	Ispaghula	Granules/ Husk/ Powder	1 gm	0.76	1461(E)	02.04.2018
449	IUD containing Copper	As licensed	1 IUD	281.35	1461(E)	02.04.2018
450	Japanese Encephalitis Vaccine	4mcg to 6mcg	Each Pack	682.64	1461(E)	02.04.2018
451	Japanese Encephalitis Vaccine	up to 3mcg	Each Pack	520.08	1461(E)	02.04.2018
452	Kanamycin	Powder for Injection 1 gm	Each Pack	38.27	1461(E)	02.04.2018
453	Kanamycin	Powder for Injection 500 mg	Each Pack	20.88	1461(E)	02.04.2018
454	Kanamycin	Powder for Injection 750 mg	Each Pack	35.67	1461(E)	02.04.2018
455	Ketamine	Injection 10 mg/ml	1 ml	10.36	1461(E)	02.04.2018
456	Ketamine	Injection 50 mg/ml	1 ml	10.23	1461(E)	02.04.2018
457	Labetalol	Injection 5 mg/ml	1 ml	49.61	1461(E)	02.04.2018

458	Lactulose	Oral Liquid 10 g/15 ml	1 ml	1.07	1461(E)	02.04.2018
459	Lamivudine (A) + Nevirapine (B) + Stavudine (C)	Tablet 150 mg(A) + 200 mg(B) + 30 mg(C)	1 Tablet	15.27	1461(E)	02.04.2018
460	Lamivudine (A) + Zidovudine (B)	Tablet 150 mg(A) + 300 mg(B)	1 Tablet	19.63	1461(E)	02.04.2018
461	Lamivudine (A)+ Nevirapine (B) + Stavudine (C)	Dispersible Tablet 30 mg(A) + 50 mg(B) + 6 mg(C)	1 Tablet	4.84	1461(E)	02.04.2018
462	L-Asparaginase	Powder for Injection 10000 KU	Each Pack	1571.02	1461(E)	02.04.2018
463	L-Asparaginase	Powder for Injection 5000KU	Each Pack	1014.08	1461(E)	02.04.2018
464	Leflunomide	Tablet 10 mg	1 Tablet	9.80	1461(E)	02.04.2018
465	Leflunomide	Tablet 20 mg	1 Tablet	19.12	1461(E)	02.04.2018
466	Letrozole	Tablet 2.5 mg	1 Tablet	39.90	1461(E)	02.04.2018
467	Levetiracetam	Injection 100 mg/ml	1 ml	21.35	1461(E)	02.04.2018
468	Levetiracetam	ER Tablet 750 mg	1 Tablet	17.02	1461(E)	02.04.2018
469	Levetiracetam	Tablet 250 mg	1 Tablet	5.72	1461(E)	02.04.2018
470	Levetiracetam	Tablet 500 mg	1 Tablet	11.57	1461(E)	02.04.2018
471	Levetiracetam	Tablet 750 mg	1 Tablet	17.79	1461(E)	02.04.2018
472	Levetiracetam	Oral Liquid 100 mg/ml	1 ml	3.57	1461(E)	02.04.2018
473	Levodopa (A) + Carbidopa (B)	CR Tablet 100 mg(A) + 25 mg(B)	1 Tablet	3.26	1461(E)	02.04.2018
474	Levodopa (A) + Carbidopa (B)	Tablet 100 mg(A) + 10 mg(B)	1 Tablet	1.52	1461(E)	02.04.2018
475	Levodopa (A) + Carbidopa (B)	Tablet 100 mg(A) + 25 mg(B)	1 Tablet	2.21	1461(E)	02.04.2018
476	Levodopa (A) + Carbidopa (B)	Tablet 250 mg(A) + 25 mg(B)	1 Tablet	3.66	1461(E)	02.04.2018
477	Levodopa (A) + Carbidopa (B)	CR Tablet 200 mg(A) + 50 mg(B)	1 Tablet	4.02	1461(E)	02.04.2018
478	Levofloxacin	Tablet 250 mg	1 Tablet	4.32	1461(E)	02.04.2018
479	Levofloxacin	Tablet 750 mg	1 Tablet	10.70	1461(E)	02.04.2018
480	Levofloxacin	Tablet 500mg	1 Tablet	7.89	1461(E)	02.04.2018
481	Levonorgestrel	Tablet 0.75 mg	1 Tablet	22.53	1461(E)	02.04.2018
482	Levothyroxine	Tablet 100 mcg	1 Tablet	1.17	1461(E)	02.04.2018
483	Levothyroxine	Tablet 112mcg	1 Tablet	1.40	1461(E)	02.04.2018
484	Levothyroxine	Tablet 12.5 mcg	1 Tablet	1.32	1461(E)	02.04.2018
485	Levothyroxine	Tablet 125 mcg	1 Tablet	1.50	1461(E)	02.04.2018
486	Levothyroxine	Tablet 150 mcg	1 Tablet	1.51	1461(E)	02.04.2018
487	Levothyroxine	Tablet 25 mcg	1 Tablet	1.28	1461(E)	02.04.2018
488	Levothyroxine	Tablet 50 mcg	1 Tablet	0.96	1461(E)	02.04.2018
489	Levothyroxine	Tablet 62.5mcg	1 Tablet	1.37	1461(E)	02.04.2018
490	Levothyroxine	Tablet 75 mcg	1 Tablet	1.27	1461(E)	02.04.2018
491	Levothyroxine	Tablet 88 mcg	1 Tablet	1.50	1461(E)	02.04.2018
492	Lignocaine	Injection 2%	1 ml	0.96	1461(E)	02.04.2018
493	Lignocaine	Injection 2%(Preservative free for IV use)	1 ml	0.95	1461(E)	02.04.2018
494	Lignocaine	Injection 1%	Each Pack	7.77	1461(E)	02.04.2018
495	Lignocaine	Topical Forms 2-5%	1 gm or 1 ml	1.05	1461(E)	02.04.2018
496	Lignocaine	Injection 5% with 7.5% Glucose	1 ml	3.60	1461(E)	02.04.2018
497	Lignocaine (A) + Adrenaline (B)	Injection 1% (A) + 1:200000 (5 mcg/ml) (B)	1 ml	0.44	1461(E)	02.04.2018
498	Lignocaine (A) + Adrenaline (B)	Injection 2% (A) +	1 ml	0.90	1461(E)	02.04.2018

		1:200000 (5mcg/ml) (B)
499	Linezolid	Tablet 600 mg	1 Tablet	32.33	1461(E)	02.04.2018
500	Lithium	Tablet 300 mg	1 Tablet	1.43	1461(E)	02.04.2018
501	Loperamide	Capsule 2 mg	1 Capsule	3.50	1461(E)	02.04.2018
502	Loperamide	Tablet 2 mg	1 Tablet	1.93	1461(E)	02.04.2018
503	Lopinavir (A) + Ritonavir (B)	Tablet 100 mg(A) + 25 mg(B)	1 Tablet	23.01	1461(E)	02.04.2018
504	Lopinavir (A) + Ritonavir (B)	Tablet 200 mg(A) + 50 mg(B)	1 Tablet	44.59	1461(E)	02.04.2018
505	Lorazepam	injection 2 mg/ml	1 ml	7.61	1461(E)	02.04.2018
506	Lorazepam	Tablet 1 mg	1 Tablet	2.02	1461(E)	02.04.2018
507	Lorazepam	Tablet 2 mg	1 Tablet	2.46	1461(E)	02.04.2018
508	Magnesium Sulphate	Injection 500 mg/ml	1 ml	4.67	1461(E)	02.04.2018
509	Mannitol	Injection 10%	1 ml	0.16	1461(E)	02.04.2018
510	Mannitol	Injection 20%	1 ml	0.29	1461(E)	02.04.2018
511	Measles Rubbela Vaccine		Each Pack (0.5ml)	86.52	1461(E)	02.04.2018
512	Measles vaccine	Vaccine	Each Pack (0.5ml)	49.90	1461(E)	02.04.2018
513	Mebendazole	Oral Liquid 100 mg/5ml	1 ml	0.76	1461(E)	02.04.2018
514	Mebendazole	Tablet 100 mg	1 Tablet	2.87	1461(E)	02.04.2018
515	Medroxyprogesteroneacetate	Tablet 10 mg	1 Tablet	5.27	1461(E)	02.04.2018
516	Mefenamic acid	Oral Liquid 100 mg/5ml	1 ml	0.51	1461(E)	02.04.2018
517	Mefenamic acid	Tablet 250 mg	1 Tablet	1.89	1461(E)	02.04.2018
518	Mefenamic acid	Tablet 500 mg	1 Tablet	2.40	1461(E)	02.04.2018
519	Mefloquine	Tablet 250 mg	1 Tablet	49.89	1461(E)	02.04.2018
520	Meglumine Diatrizoate	Injection 60%w/v	1 ml	8.09	1461(E)	02.04.2018
521	Meglumine Diatrizoate	Injection 76%w/v	1 ml	9.34	1461(E)	02.04.2018
522	Melphalan	Tablet 2 mg	1 Tablet	96.01	1461(E)	02.04.2018
523	Melphalan	Tablet 5 mg	1 Tablet	164.67	1461(E)	02.04.2018
524	Mesna	Injection 100 mg/ml	1 ml	16.41	1461(E)	02.04.2018
525	Metformin	Immediate Release Tablet 500 mg	1 Tablet	1.47	1461(E)	02.04.2018
526	Metformin	Controlled Release Tablet 1000 mg	1 Tablet	3.57	1461(E)	02.04.2018
527	Metformin	Controlled Release Tablet 500 mg	1 Tablet	1.87	1461(E)	02.04.2018
528	Metformin	controlled Released Tablet 750 mg	1 Tablet	2.35	1461(E)	02.04.2018
529	Metformin	Immediate Release Tablet 1000 mg	1 Tablet	3.52	1461(E)	02.04.2018
530	Metformin	Immediate Release Tablet 750 mg	1 Tablet	2.97	1461(E)	02.04.2018
531	Methotrexate	Injection 25 mg/ml	1 ml	47.07	1461(E)	02.04.2018
532	Methotrexate	Injection 50 mg/ml	1 ml	39.20	1461(E)	02.04.2018
533	Methotrexate	Tablet 10 mg	1 Tablet	11.89	1461(E)	02.04.2018
534	Methotrexate	Tablet 2.5 mg	1 Tablet	4.68	1461(E)	02.04.2018
535	Methotrexate	Tablet 7.5 mg	1 Tablet	11.34	1461(E)	02.04.2018
536	Methotrexate	Tablet 5 mg	1 Tablet	8.20	1461(E)	02.04.2018
537	Methyldopa	Tablet 250 mg	1 Tablet	2.39	1461(E)	02.04.2018
538	Methyldopa	Tablet 500 mg	1 Tablet	4.58	1461(E)	02.04.2018
539	Methylergometrine	Injection 0.2 mg/ml	1 ml	13.97	1461(E)	02.04.2018
540	Methylergometrine	Tablet 0.125 mg	1 Tablet	7.75	1461(E)	02.04.2018
541	Methylprednisolone	Tablet 16 mg	1 Tablet	8.73	1461(E)	02.04.2018
542	Methylprednisolone	Tablet 8 mg	1 Tablet	4.99	1461(E)	02.04.2018
543	Methylprednisolone	Injection 40mg/ml	1 ml	52.81	1461(E)	02.04.2018

544	Metoclopramide	Injection 5 mg/ml (10 ml Pack)	1 ml	1.39	1461(E)	02.04.2018
545	Metoclopramide	Injection 5 mg/ml (2 ml Pack)	1 ml	2.29	1461(E)	02.04.2018
546	Metoclopramide	Oral Liquid 5 mg/5ml	1 ml	0.43	1461(E)	02.04.2018
547	Metoclopramide	Tablet 10 mg	1 Tablet	1.14	1461(E)	02.04.2018
548	Metoprolol	Capsule 25 mg	1 Capsule	4.14	1461(E)	02.04.2018
549	Metoprolol	Capsule 50 mg	1 Capsule	6.31	1461(E)	02.04.2018
550	Metoprolol	SR Tablet 25 mg	1 Tablet	3.95	1461(E)	02.04.2018
551	Metoprolol	SR Tablet 50 mg	1 Tablet	5.65	1461(E)	02.04.2018
552	Metoprolol	Tablet 25 mg	1 Tablet	3.04	1461(E)	02.04.2018
553	Metoprolol	Tablet 50 mg	1 Tablet	4.61	1461(E)	02.04.2018
554	Metronidazole	Injection 500mg/100ml	1 ml	0.13	1461(E)	02.04.2018
555	Metronidazole	Oral Liquid 200 mg/5ml	1 ml	0.29	1461(E)	02.04.2018
556	Metronidazole	Tablet 200 mg	1 Tablet	0.45	3983(E)	13.08.2018
557	Metronidazole	Tablet 400 mg	1 Tablet	0.83	3983(E)	13.08.2018
558	Midazolam	Injection 1 mg/ml	1 ml	5.78	1461(E)	02.04.2018
559	Midazolam	Injection 5 mg/ml	1 ml	14.20	1461(E)	02.04.2018
560	Midazolam	Tablet 7.5mg	1 Tablet	21.97	1461(E)	02.04.2018
561	Mifepristone	Tablet 200 mg	1 Tablet	314.84	1461(E)	02.04.2018
562	Misoprostol	Tablet 100 mcg	1 Tablet	8.52	1461(E)	02.04.2018
563	Misoprostol	Tablet 200 mcg	1 Tablet	16.34	1461(E)	02.04.2018
564	Morphine	Injection 10 mg/ml	1 ml	23.24	1461(E)	02.04.2018
565	Morphine	Injection 15 mg/ml	1 ml	29.00	1461(E)	02.04.2018
566	Morphine	SR Tablet 30 mg	1 Tablet	5.33	1461(E)	02.04.2018
567	Morphine	Tablet 10 mg	1 Tablet	5.21	1461(E)	02.04.2018
568	Moxifloxacin	Tablet 400 mg	1 Tablet	24.79	1461(E)	02.04.2018
569	Mycophenolate mofetil	Tablet 250 mg	1 Tablet	40.63	1461(E)	02.04.2018
570	Mycophenolate mofetil	Tablet 500 mg	1 Tablet	80.38	1461(E)	02.04.2018
571	N-acetylcysteine	Injection 200 mg/ml	1 ml	21.93	1461(E)	02.04.2018
572	N-acetylcysteine	Sachet 200mg	1 gm	8.80	1461(E)	02.04.2018
573	Naloxone	injection 0.4 mg/ml	1 ml	84.90	1461(E)	02.04.2018
574	Natamycin	Drops 5%	1 ml	22.32	1461(E)	02.04.2018
575	Neostigmine	injection 0.5 mg/ml	1 ml	4.26	1461(E)	02.04.2018
576	Neostigmine	Tablet 15 mg	1 Tablet	4.57	1461(E)	02.04.2018
577	Nevirapine	Oral Liquid 50 mg/5ml	1 ml	0.82	1461(E)	02.04.2018
578	Nevirapine	Tablet 200 mg	1 Tablet	14.01	1461(E)	02.04.2018
579	Nifedipine	Capsule 10 mg	1 Capsule	0.84	1461(E)	02.04.2018
580	Nifedipine	Tablet 10 mg	1 Tablet	1.21	1461(E)	02.04.2018
581	Nitrofurantoin	Oral Liquid 25 mg/5ml	1 ml	0.80	1461(E)	02.04.2018
582	Nitrofurantoin	Tablet 100 mg	1 Tablet	7.08	1461(E)	02.04.2018
583	Nitrofurantoin	Capsule 100mg	1 Capsule	7.69	1461(E)	02.04.2018
584	Nitrous Oxide	Inhalation	Cubic Meter	228.65	5634(E)	02.11.2018
585	Noradrenaline	Injection 2 mg/ml	1 ml	25.21	1461(E)	02.04.2018
586	Norethisterone	Tablet 5 mg	1 Tablet	5.00	1461(E)	02.04.2018
587	Omeprazole	Capsule 10 mg	1 Capsule	2.07	1461(E)	02.04.2018
588	Omeprazole	Capsule 20 mg	1 Capsule	2.44	1461(E)	02.04.2018
589	Omeprazole	Capsule 40 mg	1 Capsule	4.83	1461(E)	02.04.2018
590	Omeprazole	Powder for oral Liquid 20 mg	1 gm	1.20	1461(E)	02.04.2018
591	Omeprazole	Tablet 10 mg	1 Tablet	4.34	1461(E)	02.04.2018
592	Omeprazole	Tablet 20 mg	1 Tablet	4.82	1461(E)	02.04.2018
593	Omeprazole	Tablet 40 mg	1 Tablet	8.16	1461(E)	02.04.2018
594	Ondansetron	Injection 2 mg/ml	1 ml	5.72	1461(E)	02.04.2018

595	Ondansetron	Oral Liquid 2 mg/5ml	1 ml	1.11	1461(E)	02.04.2018
596	Ondansetron	Tablet 4 mg	1 Tablet	4.60	1461(E)	02.04.2018
597	Ondansetron	Tablet 8 mg	1 Tablet	9.55	1461(E)	02.04.2018
598	Oral Rehydration Salts	As Licensed	1 gm	0.87	2399(E)	12.06.2018
599	Oral Rehydration Salts	As Licensed	1 ml	0.14	1461(E)	02.04.2018
600	Oxaliplatin	Injection 100mg(as licensed)	Each Pack	4373.47	1461(E)	02.04.2018
601	Oxaliplatin	Injection 50mg(as licensed)	Each Pack	2543.51	3983(E)	13.08.2018
602	Oxygen	Inhalation (Medicinal gas)	Cubic Meter	17.17	5634(E)	02.11.2018
603	Oxytocin	Injection 10 IU/ml	1 ml	38.55	1461(E)	02.04.2018
604	Oxytocin	Injection 5IU/ml	1 ml	17.27	1461(E)	02.04.2018
605	Paclitaxel	Injection 100 mg/16.7 ml	1 ml	218.41	1461(E)	02.04.2018
606	Paclitaxel	Injection 30 mg/ 5ml	1 ml	218.41	1461(E)	02.04.2018
607	Pantoprazole	Injection 40 mg	Each Pack	43.57	1461(E)	02.04.2018
608	Para-aminosalicylic acid	Granules (As licensed)	1 gm	2.78	1461(E)	02.04.2018
609	Paracetamol	Oral Liquid 100 mg/5ml	1 ml	0.50	1461(E)	02.04.2018
610	Paracetamol	Oral Liquid 120 mg/5ml	1 ml	0.52	1461(E)	02.04.2018
611	Paracetamol	Oral Liquid 125 mg/5ml	1 ml	0.33	1461(E)	02.04.2018
612	Paracetamol	Oral Liquid 150 mg/5ml	1 ml	0.57	1461(E)	02.04.2018
613	Paracetamol	Oral Liquid 250 mg/5ml	1 ml	0.59	1461(E)	02.04.2018
614	Paracetamol	Oral Liquid 500 mg/5ml	1 ml	0.63	1461(E)	02.04.2018
615	Paracetamol	Oral Liquid 650 mg/5ml	1 ml	0.51	1461(E)	02.04.2018
616	Paracetamol	Tablet 500 mg	1 Tablet	0.89	1461(E)	02.04.2018
617	Paracetamol	Tablet 650 mg	1 Tablet	1.80	1461(E)	02.04.2018
618	Paracetamol	Injection 150 mg/ml	Each Pack ( 0.5 ml)	3.00	1461(E)	02.04.2018
619	Paracetamol	Injection 150 mg/ml	Each Pack (1 ml)	4.11	1461(E)	02.04.2018
620	Paracetamol	Injection 150 mg/ml	Each Pack (2 ml)	6.31	1461(E)	02.04.2018
621	Paracetamol	Injection 150 mg/ml	Each Pack (3 ml)	8.52	1461(E)	02.04.2018
622	Paracetamol	Injection 150 mg/ml	Each Pack (4 ml)	10.73	1461(E)	02.04.2018
623	Paracetamol	Injection 150 mg/ml	Each Pack (5 ml)	12.94	1461(E)	02.04.2018
624	Paracetamol	Injection 150 mg/ml	Each Pack (7 ml)	17.35	1461(E)	02.04.2018
625	Paracetamol	Suppository 170 mg	Each Suppository	7.53	1461(E)	02.04.2018
626	Paracetamol	Suppository 80 mg	Each Suppository	6.37	1461(E)	02.04.2018
627	Paracetamol Oral Liquid	100 mg/ml (pediatric)	1 ml	1.58	5633(E)	02.11.2018
628	Pegylated interferon alfa 2a	Injection 180mcg	Each Pack	7743.81	1461(E)	02.04.2018
629	Pegylated interferon alfa 2b	Injection 100mcg	Each Pack	15310.45	1461(E)	02.04.2018
630	Pegylated interferon alfa 2b	Injection 120mcg	Each Pack	14258.36	1461(E)	02.04.2018
631	Pegylated interferon alfa 2b	Injection 80mcg	Each Pack	12240.27	1461(E)	02.04.2018
632	Penicillamine	Capsule 250 mg	1 Capsule	14.55	1461(E)	02.04.2018

633	Permethrin	Cream 1%	1 gm	1.57	1461(E)	02.04.2018
634	Permethrin	Cream 5%	1 gm	1.70	1461(E)	02.04.2018
635	Permethrin	Gel 5%	1 gm	1.43	1461(E)	02.04.2018
636	Permethrin	Lotion 1%	1 gm	0.89	1461(E)	02.04.2018
637	Permethrin	Lotion 5%	1 ml	0.95	1461(E)	02.04.2018
638	Pheniramine	Injection 22.75 mg/ml (2ml)	1 ml	1.49	1461(E)	02.04.2018
639	Pheniramine	Injection 22.75 mg/ml(10ml)	1 ml	1.11	1461(E)	02.04.2018
640	Phenobarbitone	Injection 200 mg/ml	1 ml	18.76	1461(E)	02.04.2018
641	Phenobarbitone	Tablet 30 mg	1 Tablet	1.20	1461(E)	02.04.2018
642	Phenobarbitone	Tablet 60 mg	1 Tablet	1.73	1461(E)	02.04.2018
643	Phenobarbitone	Oral liquid 20 mg/5 ml	1 ml	0.43	1461(E)	02.04.2018
644	Phenylephrine	Drop 10%	1 ml	7.91	1461(E)	02.04.2018
645	Phenylephrine	Drops 5%	1 ml	3.65	1461(E)	02.04.2018
646	Phenytoin	Capsule 100 mg	1 Capsule	1.49	1461(E)	02.04.2018
647	Phenytoin	Capsule 300 mg	1 Capsule	3.73	1461(E)	02.04.2018
648	Phenytoin	ERCapsule 300 mg	1 Capsule	3.73	1461(E)	02.04.2018
649	Phenytoin	injection 25 mg/ml	1 ml	2.46	1461(E)	02.04.2018
650	Phenytoin	Injection 50 mg/ml	1 ml	5.26	1461(E)	02.04.2018
651	Phenytoin	Oral Liquid 125 mg/5ml	1 ml	0.88	1461(E)	02.04.2018
652	Phenytoin	Oral Liquid 30 mg/5ml	1 ml	0.30	1768(E)	26.04.2018
653	Phenytoin	ER Tablet 300 mg	1 Tablet	5.68	1461(E)	02.04.2018
654	Phenytoin	Tablet 100 mg	1 Tablet	1.52	1461(E)	02.04.2018
655	Phenytoin	Tablet 300 mg	1 Tablet	4.64	1461(E)	02.04.2018
656	Phenytoin	Tablet 50 mg	1 Tablet	0.73	1461(E)	02.04.2018
657	Phytomenadione (Vitamin K1)	Injection 10mg/ml	1 ml	46.86	1461(E)	02.04.2018
658	Phytomenadione (Vitamin K1)	Tablet 10mg	1 Tablet	14.21	5633(E)	02.11.2018
659	Pilocarpine	Drops 2%	1 ml	9.89	1461(E)	02.04.2018
660	Pilocarpine	Drops 4%	1 ml	11.43	1461(E)	02.04.2018
661	Piperacillin (A) + Tazobactam (B)	Powder for Injection 1 g (A) + 125 mg(B)	Each Pack	86.51	1461(E)	02.04.2018
662	Piperacillin (A) + Tazobactam (B)	Powder for Injection 2 g (A) + 250 mg(B)	Each Pack	204.65	1461(E)	02.04.2018
663	Piperacillin (A) + Tazobactam (B)	Powder for Injection 4 g (A) + 500 mg(B)	Each Pack	429.90	1461(E)	02.04.2018
664	Potassium chloride	Injection 150 mg/ml	1 ml	2.38	1461(E)	02.04.2018
665	Potassium chloride	Oral Liquid 500 mg/5ml	1 ml	0.28	1461(E)	02.04.2018
666	Potassium permanganate	Crystals for topical solution	1 gm	0.43	1461(E)	02.04.2018
667	Povidone iodine	Solution 4%	1 ml	1.70	1461(E)	02.04.2018
668	Povidone iodine	Solution 7.5%	1 ml	0.76	1461(E)	02.04.2018
669	Povidone Iodine	Solution 10%	1 ml	0.91	6252(E)	21.12.2018
670	Povidone Iodine	Solution 5%	1 ml	0.38	1461(E)	02.04.2018
671	Pralidoxime chloride (2-PAM)	Injection 25 mg/ml	1 ml	3.65	1461(E)	02.04.2018
672	Prednisolone	Drops 1%	1 ml	3.28	1461(E)	02.04.2018
673	Prednisolone	Injection 20 mg/2ml	1 ml	3.50	1461(E)	02.04.2018
674	Prednisolone	Oral Liquid 15 mg/ 5ml	1 ml	0.74	1461(E)	02.04.2018
675	Prednisolone	Oral Liquid 5 mg/ 5ml	1 ml	0.42	1461(E)	02.04.2018
676	Prednisolone	Tablet 10 mg	1 Tablet	0.95	1461(E)	02.04.2018
677	Prednisolone	Tablet 20 mg	1 Tablet	1.91	1461(E)	02.04.2018
678	Prednisolone	Tablet 40 mg	1 Tablet	2.75	1461(E)	02.04.2018
679	Prednisolone	Tablet 5 mg	1 Tablet	0.55	1461(E)	02.04.2018

680	Premix Insulin 30:70 Injection (Regular:NPH)	Injection 40 IU /ml	1 ml	14.73	1461(E)	02.04.2018
681	Prilocaine (A) + Lignocaine (B)	Cream 2.5% (A) + 2.5% (B )	1 gm	20.01	1461(E)	02.04.2018
682	Primaquine	Tablet 15 mg	1 Tablet	4.48	1461(E)	02.04.2018
683	Primaquine	Tablet 2.5 mg	1 Tablet	1.52	1461(E)	02.04.2018
684	Primaquine	Tablet 7.5 mg	1 Tablet	2.07	1461(E)	02.04.2018
685	Procarbazine	Capsule 50 mg	1 Capsule	33.83	1461(E)	02.04.2018
686	Procarbazine	Tablet 50 mg	1 Tablet	46.10	1461(E)	02.04.2018
687	Proparacaine	Drops 0.5%	1 ml	9.76	1461(E)	02.04.2018
688	Propofol	Injection 10 mg/ml	1 ml	7.07	1461(E)	02.04.2018
689	Propranolol	Capsule 40 mg	1 Capsule	3.72	1461(E)	02.04.2018
690	Propranolol	Capsule 80 mg	1 Capsule	5.65	1461(E)	02.04.2018
691	Propranolol	Tablet 10 mg	1 Tablet	1.14	1461(E)	02.04.2018
692	Propranolol	Tablet 40 mg	1 Tablet	2.70	1461(E)	02.04.2018
693	Propranolol	Tablet 80 mg	1 Tablet	4.89	1461(E)	02.04.2018
694	Protamine	Injection 10 mg/ml	1 ml	9.05	1461(E)	02.04.2018
695	Pyrazinamide	Oral Liquid 250 mg/5ml	1 ml	0.60	1461(E)	02.04.2018
696	Pyrazinamide	Tablet 1000 mg	1 Tablet	9.23	1461(E)	02.04.2018
697	Pyrazinamide	Tablet 1500 mg	1 Tablet	10.22	1461(E)	02.04.2018
698	Pyrazinamide	Tablet 500 mg	1 Tablet	4.14	1461(E)	02.04.2018
699	Pyrazinamide	Tablet 750 mg	1 Tablet	6.30	1461(E)	02.04.2018
700	Pyridoxine	Tablet 100 mg	1 Tablet	5.47	1461(E)	02.04.2018
701	Pyridoxine	Tablet 10mg	1 Tablet	0.11	1461(E)	02.04.2018
702	Quinine	Injection 300 mg/ml	1 ml	9.95	1461(E)	02.04.2018
703	Quinine	Tablet 300 mg	1 Tablet	5.60	1461(E)	02.04.2018
704	Rabies Vaccine		Each Pack	334.42	1461(E)	02.04.2018
705	Raltegravir	Tablet 400 mg	1 Tablet	153.15	1461(E)	02.04.2018
706	Ramipril	Capsule 2.5 mg	1 Capsule	4.63	1461(E)	02.04.2018
707	Ramipril	Capsule 5 mg	1 Capsule	7.23	1461(E)	02.04.2018
708	Ramipril	Tablet 2.5 mg	1 Tablet	4.87	1461(E)	02.04.2018
709	Ramipril	Tablet 5 mg	1 Tablet	7.67	1461(E)	02.04.2018
710	Ranitidine	Oral Liquid 75 mg/5ml	1 ml	0.71	3983(E)	13.08.2018
711	Ranitidine	Tablet 150 mg	1 Tablet	0.72	1461(E)	02.04.2018
712	Ranitidine	Injection 25mg/ml	1 ml	1.58	1461(E)	02.04.2018
713	Ribavirin	Capsule 200 mg	1 Capsule	81.86	1461(E)	02.04.2018
714	Rifabutin	Capsule 150mg	1 Capsule	38.82	1461(E)	02.04.2018
715	Rifabutin	Tablet 150mg	1 Tablet	36.25	1461(E)	02.04.2018
716	Rifampicin	Capsule 150 mg	1 Capsule	1.96	1461(E)	02.04.2018
717	Rifampicin	Capsule 300 mg	1 Capsule	3.72	1461(E)	02.04.2018
718	Rifampicin	Capsule 450 mg	1 Capsule	4.83	1461(E)	02.04.2018
719	Rifampicin	Capsule 600 mg	1 Capsule	11.35	1461(E)	02.04.2018
720	Rifampicin	Oral Liquid 100 mg/5ml	1 ml	0.38	1461(E)	02.04.2018
721	Rifampicin	Tablet 150 mg	1 Tablet	1.58	1461(E)	02.04.2018
722	Rifampicin	Tablet 300 mg	1 Tablet	2.87	1461(E)	02.04.2018
723	Ringer Lactate	Injection 1000ml	Each Pack	78.06	1461(E)	02.04.2018
724	Ringer Lactate	Injection 100ml	Each Pack	20.44	1461(E)	02.04.2018
725	Ringer Lactate	Injection 250ml	Each Pack	34.85	1461(E)	02.04.2018
726	Ringer Lactate	Injection 500ml	Each Pack	44.41	1461(E)	02.04.2018
727	Risperidone	Oral Liquid 1 mg/ml	1 ml	1.89	1461(E)	02.04.2018
728	Risperidone	Tablet 1 mg	1 Tablet	3.01	1461(E)	02.04.2018
729	Risperidone	Tablet 2 mg	1 Tablet	4.82	1461(E)	02.04.2018
730	Risperidone	Tablet 4 mg	1 Tablet	9.79	1461(E)	02.04.2018
731	Ritonavir	Capsule 100 mg	1 Capsule	27.62	1461(E)	02.04.2018
732	Ritonavir	Tablet 100 mg	1 Tablet	28.40	1461(E)	02.04.2018

733	Rituximab	Injection 10 mg/ml	1 ml	742.27	1461(E)	02.04.2018
734	Salbutamol	Capsule 4 mg	1 Capsule	0.59	1461(E)	02.04.2018
735	Salbutamol	Inhalation (MDI/DPI) 100 mcg/dose	1 Dose	0.39	1461(E)	02.04.2018
736	Salbutamol	Oral Liquid 2 mg/5ml	1 ml	0.15	1461(E)	02.04.2018
737	Salbutamol	Respirator solution for use in Nebulizer 5 mg/ml	1 ml	0.69	1461(E)	02.04.2018
738	Salbutamol	Tablet 2 mg	1 Tablet	0.16	1461(E)	02.04.2018
739	Salbutamol	Tablet 4 mg	1 Tablet	0.18	1461(E)	02.04.2018
740	Salicylic acid	Ointment 6%	1 gm	1.76	1461(E)	02.04.2018
741	Sevoflurane	Inhalation	1 ml	29.27	3983(E)	13.08.2018
742	Silver Sulphadiazine	Cream 1%	1 gm	0.29	1461(E)	02.04.2018
743	Snake venom antiserum- Lyophilized polyvalent	Powder for Injection	10 ml Pack	545.31	1461(E)	02.04.2018
744	Snake Venom Antiserum-Soluble/ Liquid Polyvalent	Injection	Each Pack (10 ML)	423.47	1461(E)	02.04.2018
745	Sodium Bicarbonate	Injection 7.5%	1 ml	1.37	1461(E)	02.04.2018
746	Sodium Bicarbonate	Injection 8.4%	1 ml	1.26	1461(E)	02.04.2018
747	Sodium Chloride	Injection 0.9%	1000ml Glass	58.08	1461(E)	02.04.2018
748	Sodium Chloride	Injection 0.9%	1000ml Non- Glass	45.81	1461(E)	02.04.2018
749	Sodium Chloride	Injection 0.9%	100ml Glass	17.18	1461(E)	02.04.2018
750	Sodium Chloride	Injection 0.9%	100ml Non- Glass	15.47	1461(E)	02.04.2018
751	Sodium Chloride	Injection 0.9%	250ml Glass	23.16	1461(E)	02.04.2018
752	Sodium Chloride	Injection 0.9%	250ml Non- Glass	20.80	1461(E)	02.04.2018
753	Sodium Chloride	Injection 0.9%	500ml Glass	32.20	1461(E)	02.04.2018
754	Sodium Chloride	Injection 0.9%	500ml Non- Glass	27.41	1461(E)	02.04.2018
755	Sodium Nitroprusside	Injection 10 mg/ml	1 ml	25.26	1461(E)	02.04.2018
756	Sodium Valproate	Injection 100 mg/ml	1 ml	5.64	1461(E)	02.04.2018
757	Sodium Valproate	Oral Liquid 200 mg/5ml	1 ml	0.57	1461(E)	02.04.2018
758	Sodium Valproate	CR Tablets 300mg	1 Tablet	6.16	1461(E)	02.04.2018
759	Sodium Valproate	CR Tablets 500mg	1 Tablet	9.54	1461(E)	02.04.2018
760	Sodium Valproate	Tablet 200 mg	1 Tablet	3.03	1461(E)	02.04.2018
761	Sodium Valproate	Tablet 300 mg	1 Tablet	3.89	1461(E)	02.04.2018
762	Sodium Valproate	Tablet 500 mg	1 Tablet	6.79	1461(E)	02.04.2018
763	Sofosbuvir	Tablet 400 mg	1 Tablet	653.21	1461(E)	02.04.2018
764	Somatostatin	Powder for Injection 3 mg	Each pack	1550.94	1461(E)	02.04.2018
765	Spironolactone	Tablet 25 mg	1 Tablet	1.87	1461(E)	02.04.2018
766	Spironolactone	Tablet 50 mg	1 Tablet	3.72	1461(E)	02.04.2018
767	Stavudine (A) + Lamivudine (B)	Tablet 30 mg(A) +150 mg(B)	1 Tablet	9.34	1461(E)	02.04.2018
768	Streptokinase	Injection 15,00,000 IU	Each Pack	1751.76	1461(E)	02.04.2018
769	Streptokinase	Injection 7,50,000 IU	Each Pack	1232.06	1461(E)	02.04.2018
770	Streptomycin	Powder for Injection 750 mg	Each Pack	8.59	1461(E)	02.04.2018
771	Streptomycin	Powder for Injection 1 gm	Each Pack	10.21	1461(E)	02.04.2018
772	Succinyl Choline	Injection 50 mg/ml	1 ml	4.73	1461(E)	02.04.2018
773	Sucralfate	Oral Liquid 1 g	1 ml	0.69	1461(E)	02.04.2018
774	Sulfasalazine	Tablet 500 mg	1 Tablet	3.90	1461(E)	02.04.2018
775	Sumatriptan	Tablet 25mg	1 Tablet	32.58	1461(E)	02.04.2018
776	Sumatriptan	Tablet 50mg	1 Tablet	50.43	1461(E)	02.04.2018

777	Surfactant	Suspension for intratracheal instillation (As liensed)	Per mg of Phospholipids in the pack	65.46	1461(E)	02.04.2018
778	Tacrolimus	Capsule 0.5 mg	1 Capsule	21.64	1461(E)	02.04.2018
779	Tacrolimus	Capsule 1 mg	1 Capsule	38.23	1461(E)	02.04.2018
780	Tacrolimus	Capsule 2 mg	1 Capsule	74.89	1461(E)	02.04.2018
781	Tamoxifen	Tablet 10 mg	1 Tablet	2.52	1461(E)	02.04.2018
782	Tamoxifen	Tablet 20 mg	1 Tablet	2.85	1461(E)	02.04.2018
783	Telmisartan	Tablet 20 mg	1 Tablet	3.57	1461(E)	02.04.2018
784	Telmisartan	Tablet 40 mg	1 Tablet	6.45	1461(E)	02.04.2018
785	Telmisartan	Tablet 80 mg	1 Tablet	9.83	1461(E)	02.04.2018
786	Temozolomide	Capsule 100 mg	1 Capsule	2039.10	1461(E)	02.04.2018
787	Temozolomide	Capsule 20 mg	1 Capsule	583.68	1461(E)	02.04.2018
788	Temozolomide	Capsule 250 mg	1 Capsule	4586.31	1461(E)	02.04.2018
789	Temozolomide	Tablet 100 mg	1 Tablet	1513.59	1461(E)	02.04.2018
790	Temozolomide	Tablet 20 mg	1 Tablet	366.71	1461(E)	02.04.2018
791	Temozolomide	Tablet 250 mg	1 Tablet	3746.29	1461(E)	02.04.2018
792	Tenofovir	Tablet 300 mg	1 Tablet	46.18	1461(E)	02.04.2018
793	Tenofovir (A) + Lamivudine (B)	Tablet 300 mg(A) + 300 mg(B)	1 Tablet	43.93	1461(E)	02.04.2018
794	Tenofovir (A) + Lamivudine (B) + Efavirenz (C)	Tablet 300 mg(A) + 300 mg(B) + 600 mg(C)	1 Tablet	100.87	1461(E)	02.04.2018
795	Tetanus Toxoid	Injection	Each Pack (0.5ml)	10.37	5727(E)	13.11.2018
796	Tetanus Toxoid	Injection	Each Pack (5 ml)	22.34	5727(E)	13.11.2018
797	Thalidomide	Capsule 100 mg	1 Capsule	59.79	1461(E)	02.04.2018
798	Thalidomide	Capsule 50 mg	1 Capsule	34.54	1461(E)	02.04.2018
799	Thiamine	Injection 100 mg/ml	1 ml	24.27	1461(E)	02.04.2018
800	Thiamine	Tablet 100 mg	1 Tablet	3.67	1461(E)	02.04.2018
801	Thiopentone	Powder for Injection 0.5 gm	Each Pack	39.86	1461(E)	02.04.2018
802	Thiopentone	Powder for Injection 1 gm	Each Pack	48.37	1461(E)	02.04.2018
803	Timolol	Drops 0.25%	1 ml	5.05	1461(E)	02.04.2018
804	Timolol	Drops 0.5%	1 ml	11.67	1461(E)	02.04.2018
805	Tiotropium	Inhalation (MDI) 9 mcg/dose	Per Metered Dose	2.17	1028(E)	26.02.2019
806	Tiotropium	Inhalation (DPI) 18 mcg/dose	Per Dose	9.09	1028(E)	26.02.2019
807	Tramadol	Capsule 50 mg	1 Capsule	4.42	1461(E)	02.04.2018
808	Tramadol	Injection 50 mg/ml (20 ml Pack)	1 ml	1.22	1461(E)	02.04.2018
809	Tramadol	Injection 50 mg/ml (upto 2 ml Pack)	1 ml	10.25	1461(E)	02.04.2018
810	Tramadol	Tablet 100 mg	1 Tablet	19.25	1461(E)	02.04.2018
811	Tramadol	Tablet 50 mg	1 Tablet	7.89	1461(E)	02.04.2018
812	Tramadol	Capsule 100 mg	1 Capsule	9.39	1461(E)	02.04.2018
813	Tranexamic acid	Injection 100 mg/ml	1 ml	14.62	1461(E)	02.04.2018
814	Tranexamic acid	Tablet 500 mg	1 Tablet	17.00	1461(E)	02.04.2018
815	Trastuzumab	Injection 440 mg/50 ml	Each Pack	58867.50	1461(E)	02.04.2018
816	Trihexyphenidyl	Tablet 2 mg	1 Tablet	1.19	1461(E)	02.04.2018
817	Tropicamide	Eye Drop 1%	1 ml	9.84	1461(E)	02.04.2018
818	Vancomycin	Powder for Injection 1 gm	Each Pack	465.74	1461(E)	02.04.2018
819	Vancomycin	Powder for Injection	Each Pack	217.00	1461(E)	02.04.2018

		250 mg
820	Vancomycin	Powder for Injection 500 mg	Each Pack	280.13	1461(E)	02.04.2018
821	Vecuronium	Powder for Injection 10 mg	Each Pack	185.03	1461(E)	02.04.2018
822	Vecuronium	Powder for Injection 4 mg	Each Pack	89.30	1461(E)	02.04.2018
823	Verapamil	Injection 2.5 mg/ml	1 ml	1.14	1461(E)	02.04.2018
824	Verapamil	Tablet 40 mg	1 Tablet	0.73	1461(E)	02.04.2018
825	Verapamil	Tablet 80 mg	1 Tablet	1.36	1461(E)	02.04.2018
826	Vinblastine	Injection 1mg/ml	1 ml	20.08	1461(E)	02.04.2018
827	Vincristine	Injection 1 mg/ml	1 ml	51.00	1461(E)	02.04.2018
828	Vitamin A	Capsule 50000 IU	1 Capsule	0.54	1461(E)	02.04.2018
829	Vitamin A	Injection 50000 IU/ml	1 ml	1.87	1461(E)	02.04.2018
830	Vitamin A	Tablet 50000 IU	1 Tablet	0.69	1461(E)	02.04.2018
831	Warfarin	Tablet 1 mg	1 Tablet	2.37	1461(E)	02.04.2018
832	Warfarin	Tablet 2 mg	1 Tablet	2.61	1461(E)	02.04.2018
833	Warfarin	Tablet 3 mg	1 Tablet	3.05	1461(E)	02.04.2018
834	Warfarin	Tablet 5 mg	1 Tablet	2.31	1461(E)	02.04.2018
835	Water for Injection	Injection	Each Pack (10 ml)	2.28	1461(E)	02.04.2018
836	Water for Injection	Injection	Each Pack (5 ml)	2.20	1461(E)	02.04.2018
837	White Petrolatum	Jelly 100%	1 gm	0.09	1461(E)	02.04.2018
838	Xylometazoline	Nasal Drops 0.05%	1 ml	3.85	1461(E)	02.04.2018
839	Xylometazoline	Nasal Drops 0.1%	1 ml	5.09	1461(E)	02.04.2018
840	Zidovudine	Capsule 300 mg	1 Capsule	2.02	1461(E)	02.04.2018
841	Zidovudine	Tablet 300 mg	1 Tablet	13.95	1461(E)	02.04.2018
842	Zidovudine (A) + Lamivudine (B) + Nevirapine (C)	Tablet 300 mg(A) + 150 mg(B) + 200 mg(C)	1 Tablet	19.72	1461(E)	02.04.2018
843	Zinc sulphate	Dispersible Tablet 20mg	1 Tablet	3.07	1461(E)	02.04.2018
844	Zoledronic Acid	Powder for Injection 4 mg	Each Pack	4111.38	1461(E)	02.04.2018
845	Zolpidem	Capsule 5 mg	1 Capsule	7.19	1461(E)	02.04.2018
846	Zolpidem	Tablet 10 mg	1 Tablet	8.26	1461(E)	02.04.2018
847	Zolpidem	Tablet 5 mg	1 Tablet	5.27	1461(E)	02.04.2018

Reference: NPPA

DPCO Price List - Nov 2018

Indian Pharmaceutical Industry to grow at 11-13% in FY2020

The rating agency ICRA said on Thursday that Indian pharmaceutical industry is likely to grow by 11-13 percent in the current fiscal.

ICRA said that the growth speed for the pharma industry is likely to remain at 11% to 13% in the financial year 2020, on the back of solid interest from the domestic market, given increasing spend on healthcare along with improving access.

“The revenue growth for the Indian pharmaceutical industry in Q4 FY2019 stood at 11.8% supported by the US and Europe. The US grew by 21.3% led by new product launches, few limited competition products, moderation in pricing pressure and market share gains. Europe continues to demonstrate good growth at 18.8% though few companies reported a decline in revenues. Growth from European markets benefitted from higher tender wins, new product introduction in B2B segments and low base effect though healthcare reforms resulting in price cuts continue to pose challenges. For US market, companies (within our sample set) witnessed positive growth momentum at 21.3% Q4FY2019 and 10.7% FY2019 compared to FY2018 growth of -13.1%, said Gaurav Jain, Vice President, ICRA.

The release also stated, "The growth would, however, be constrained by regulatory interventions such as compulsory genericization, price controls, and the United States Food and Drug Administration (USFDA) oversight for manufacturing deficiencies".

As per an ICRA report covering a sample of 21 companies in the industry, the growth during Financial Year 2019 stood at around 12 percent.

Gaurav Jain, Vice President & Co-Head, ICRA Corporate Ratings said: "The growth in FY2020 is expected to be supported by 4.2 percent WPI linked price hike for NLEM (National List of Essential Medicines) portfolio".

He also said that the credit metrics of leading pharma companies are expected to remain the same in view of future growth prospects in regulated markets and relatively strong balance sheets.

Indian Pharma gets 9% more USFDA approval

Indian Pharma companies received 372 approvals to launch generic drugs in the US fiscal 2019, up 8.6% from 340 in the previous year. The development comes even as India got 15 warning letters in calendar 2018, lower than the US with 19, and China which topped the list with 24 warning letters. As against this, India had the ignominious distinction of topping the list with 9 warning letters in 2015 and has since appeared to have cleaned up this act.
In terms of approvals, Zydus Cadila topped the list with 60, with Indian companies cornering nearly 40% volume share in highly remunerative $60-billion-plus US generic market- a key driver of growth for the domestic industry. In an indication of having resolved data integrity issues by investing in skill sets, domestic companies grabbed the opportunity by the US Food and Drug Administration (USFDA) to speed up the generic competition.
Indian generic filings have been rising year-on-year, unfazed by regulatory pressure from the USFDA, and a spate of warning letters issued to their facilities over the last couple of years. Over 2015-17, Indian companies have faced intense regulatory glare from the US, with nearly all top companies having been issued warning letters over manufacturing violations at their plants. This seems to have changed last year with fewer warning letters for Indian companies, compared to other major countries.

However, in 2018 India received fewer warning letters compared to the other nations.

India to have 2,500 new hospitals in 5 years

At the launch of certificate course on ‘Specialist Training To Tackle The Burden of NCDs’ by Federation of Indian Chambers of Commerce and Industry (FICCI) , Member (Health) NITI Aayog Dr V K Paul stated that by simplifying the work in private healthcare sector won't just make new business openings yet in addition give better healthcare services. By 2024, India is likewise likely to accomplish the WHO standard of having one doctor for every thousand patients, he said.

FICCI working jointly with NITI Aayog to find innovative techniques for firming quantity of specialized doctors. In continuation to this, FICCI has collaborated with Extension for Community Healthcare Outcomes (ECHO) to dispatch the first of its caring Diabetes Certification Course for General Practitioners (GP), considering the WHO measurements of 69.2 million Indians enduring with diabetes in 2015 and insufficient endocrinologists to convey specific consideration.

According to Dr. Paul, association with the industry through FICCI makes the ECHO model extraordinary.

He emphasized on government’s arrangements to double the quantity of UG seats by 2024 yet achieving the required number of specialist doctors is a five times increasingly troublesome plan.

Originator executive of ECHO, Dr, Sanjeev Arora shared ECHO’s vision to reach to 1 billion lives by 2025 and out of 1 billion, achieving 400 million recipients in India by utilizing the ECHO model of incorporated guided practice to train doctors.

The preliminary project for FICCI-ECHO Diabetes Certification Course is a tele-tutoring program of 20-week duration tailored to train 100 GPs on logical management of diabetic patients.

According to Brig Dr. Arvind Lal, chairman, FICCI Health Services Committee & CMD, Dr. Lal Path Labs, by empowering GPs on diabetes the board can endlessly improve persistent outcomes as about 95% of the diabetics in India are being taken care of by primary care doctors, GPs and family doctors. It will develop an Indian model of healthcare.

Manoj Jhalani, MD, National Health Mission (NHM), Ministry of Health and Family Welfare, Government of India featured that "It is imperative to enable essential wellbeing groups and general doctors (GPs). The union health ministry additionally investigating participatory methodologies for connecting with a private division like a commitment for stipends paid to DNB students at both public and private hospitals."

Indian pharma exports hit $19.14 bn, report double-digit growth after 3 yrs

The recent annual report by Pharmaceutical Export Promotion Council (Pharmexcil) claimed that the total pharma exports from India have shown a heartening double-digit growth of 10.72 percent at $19.14 billion for 2018-19 as compared to last year’s pharma exports of $17.28 billion.

Earlier, the double-digit growth in Indian pharma exports was witnessed in 2015-16, when total exports of $ 16.89 billion were registered at a growth rate of 10.17 percent. The current double-digit growth occurred after three years of flat-to-marginal export growth, mainly driven by formulations exports to North America among other destinations

Giving a performance break-up of individual categories within the pharma segment, The Union Commerce Ministry's nodal agency said that the export of drug formulations and biologicals, which grew at 12.13 percent vis a vis total growth of 10.72 percent. Thus, drug formulations and biologicals added close to $1.5 billion to the total pharma export revenues this time around.

The data shows that formulations accounted for 70.87 percent of the total pharma exports in the year 2018-19, with a total contribution of $13.56 billion.

"India's export of generics is growing 2.2 times faster as compared to global generics market growth, which is reported to have grown at just over 5 percent in 2018 calendar year," Pharmexcil said. Except December 2018, which did not show promising growth, exports of formulations through the year has done well and the average exports of formulations during the year registered $1.14 billion a month, according to the report.

Bulk drugs and drug intermediates, which is the second big category of exports after formulations, grew at 10.48 percent to reach $3.9 billion as compared to $3.5 billion last year. Export of vaccines and surgical grew 1.31 percent and 3.19 percent at $661.93 million and $569.77 million respectively in 2018-19.

Herbal products, being the only category of pharmaceuticals that showed negative growth in exports this time, registered $299 million of exports as compared to $312 million in the previous year.

The top 25 export destinations contribute approximately three fourth of the formulation exports amounting to $10.38 billion. The US maintains the position of being the largest export destination with over 38.62 percent of the total generic exports to that country at $5.24 billion.

As per the data released by the Director-General Commercial Intelligence and Statistics (GGCIS) for the month of February 2019, the pharmaceutical agency maintained that the price erosion was beginning to stagnate and recovery in margins was seen in the US.

Indian companies alone got 538 authorizations (product approvals) out of the total 1638 market authorizations granted by the US Food and Drug Administration (US FDA) in the year 2018. Indian companies are facing intense competition there as many of their approved products have six or more companies competing. "Indian companies are required to file complex generic applications and also of biosimilars to steer away from intense competition and look for higher margins. Biocon has already made a beginning in biosimilars," the report said.

PCD Pharma Companies in Gujarat

First PCD Pharma Company in Gujarat

INTAS PHARMACEUTICALS

YEAR OF ESTABLISHMENT: 1984
INDUSTRY: BIOTECHNOLOGY
NUMBER OF EMPLOYEES: 300–350 (2013)
LEGAL STATUS OF FIRM: PRIVATE LIMITED COMPANY
CERTIFICATIONS: ISO 9001:2008
LOCATION – AHMEDABAD, GUJARAT

Intas Pharmaceuticals Limited is an Indian company headquartered in Ahmedabad, India. Intas Pharmaceuticals Limited is a Public incorporated on 31 May 1985.

Second PCD Pharma Company in Gujarat

TORRENT PHARMACEUTICALS

YEAR OF ESTABLISHMENT: 1959
INDUSTRY: PHARMACEUTICALS
NUMBER OF EMPLOYEES: 8600 (2014)
LEGAL STATUS OF FIRM: PUBLIC LIMITED COMPANY
CERTIFICATIONS: ISO 9001:2008
LOCATION – AHMEDABAD, GUJARAT

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group. Based in the Indian city of Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

Third PCD Pharma Company in Gujarat

CADILA PHARMACEUTICALS

YEAR OF ESTABLISHMENT: 1951
INDUSTRY: PHARMACEUTICALS
NUMBER OF EMPLOYEES: 8000
LEGAL STATUS OF FIRM: PUBLIC LIMITED COMPANY
CERTIFICATIONS: ISO 9001:2008
LOCATION – AHMEDABAD, GUJARAT

Cadila Pharmaceuticals is a multinational research-based pharmaceutical group in India with more than 5 decades of experience in providing high-quality affordable products.

Fourth PCD Pharma Company in Gujarat

ERIS LIFESCIENCES LIMITED

YEAR OF ESTABLISHMENT: 2007
INDUSTRY: PHARMACEUTICALS
NUMBER OF EMPLOYEES: UNKNOWN
LEGAL STATUS OF FIRM: PUBLIC LIMITED COMPANY
CERTIFICATIONS: ISO 9001:2008
LOCATION – AHMEDABAD, GUJARAT

Eris Lifesciences founded by Mr. Amit Bakshi and team in 2007 is one of the fastest growing companies within the chronic and acute categories of the Indian Branded Formulations market such as cardiovascular; anti-diabetes; vitamins; gastroenterology and gynecology.

Fifth PCD Pharma Company in Gujarat

TROIKAA PHARMACEUTICALS LIMITED

YEAR OF ESTABLISHMENT: 1999
INDUSTRY: PHARMACEUTICALS
NUMBER OF EMPLOYEES: UNKNOWN
LEGAL STATUS OF FIRM: PUBLIC LIMITED COMPANY
CERTIFICATIONS: ISO 9001:2008
LOCATION – AHMEDABAD, GUJARAT

Troikaa Pharmaceuticals Limited is a Public incorporated on 17 February 1999. It is classified as Non-govt company and is registered at Registrar of Companies, Ahmedabad.

Top 10 PCD Pharma Companies in India - 2019 Update

PCD Pharma Franchise Business FAQs

Q1. What is pharma franchise?

Pharma Franchise is a franchise business. Let’s understand what a franchise business is. When a company gives permission to a person or other company to sell its products by their name. It is called franchising a business.

A franchise is an agreement between the franchisee and the franchiser. The franchisee is the entrepreneur that is going to buy the franchise from the larger company also known as the franchiser.

Q2. What is PCD Pharma and what is its full form?

Same as Pharma Franchise, Pharma PCD (Propaganda cum Distribution) Franchise refers authorization of distribution and marketing rights at monopoly basis provided by a pharmaceutical firm to Pharma distributor to use their company name or brand name on behalf of the company.

PCD Full Form - Propaganda cum Distribution learn more

Q3. Is PCD Pharma different from Pharma Franchise?

No, both PCD and Pharma Franchise are the same thing.

Q4. Is CD (Cash Discount) better or scheme better for the customer?

CD (Cash Discount) is better for the customer. The illustration is given below:

For example, a person wants to purchase medicine with cost 100 for one box

Under Cash discount

Before Discount Cost of 10 box medicine = 1000 (100*10) i.e. 100 rupees per box and 10 rupees per strip

C.D 10%

After Discount cost of 10 box = (1000-100) 900 i.e. 900/10 = 90 rupees per box and 9 rupee per strip

Under Scheme

In the above case if the customer chooses the scheme (10+1)

The cost will be 1000 rupees for 11 boxes under this scheme i.e. cost of one strip 1000/110 = 9.1 approx.

Hence the Cash discount will be more beneficial to the customer than Scheme.

Q5. What are the different modes of transportation of goods?

The different modes of transport which are used for transportation of goods are air, water, and land transport which includes rail, road. The customer has to decide which transport is most suitable for him

Name of transport/ Courier	Rate/kg (Rupees) Approx.	Time (Days) Approx.
VRL	8-12	10-12
TCI EXPRESS	8-12	10-12
TCI Freight	8-12	10-12
Shree Azad Transport co. Pvt Ltd	8-12	10-12
Nav Bharat	8-12	10-12
Jaipur Golden	8-12	10-12
Khushdil Roadways	8-12	10-12
Gati	8-12	10-12
ATC Assam	8-12	10-12
DTDC (Surface)	50	4-6
DTDC (Air)	100	1-2
The Professional (Air)	100	1-2
The Professional (Surface)	50	4-6

Q6. What is GR/LR/Bilty?

GR stands for Goods Receipt. LR Stands for Lorry Receipt. These terms are the synonyms of Bilty. This receipt is made by the Transporter once the material is loaded on the vehicle for Delivery.

Q7. What is Draft on Delivery (DOD)? Which transports provide this facility?

Draft on Delivery (DOD) is a facility by which a customer can pay for his goods at the time of delivery by demand draft. The customer generates the Demand Draft by the name of the company in the bank equal to the number of goods and hands over to the particular transporter and the transporter in return releases the goods to the customer.

Following are some of the transporters which provide the facility of DOD:

TCI Express
TCI Freight
VRL
Gati
Safe express

Q8. What is Account Ledger and how can you receive payment from a customer?

A general account ledger is an account or record used to sort, store and summarize a company's transactions. In Account Ledger, all the transactions of payment and sale of a customer are recorded in chronological order.

Following are the means by which payments can be received:

IMPS
RTGS
NEFT
Cash Deposit
Demand Draft (DOD)

Q9. What is PTR, PTS and what are the percentages of PTR, PTS (Including GST)?

PTR – Price To Retailer (28.5%) is the price at which the goods are sold to a retailer

PTS – Price To Stockist (10%) is the price at which goods are sold to stockist

Calculate PTR & PTS

Q10. What is GST?

GST (Goods and Services Tax) is an Indirect Tax which has replaced many Indirect Taxes in India. Under GST, the tax is levied at every point of sale.

The goods and services tax (GST) is a value-added tax levied on most goods and services sold for domestic consumption. The GST is paid by consumers, but it is remitted to the government by the businesses selling the goods and services. In effect, GST provides revenue for the government.

GST rates for pharmaceutical products

Q11. What is a drug license? What types of Drug License are important for us at Vibcare Pharma?

To start the Pharma business, a drug license is required. The central drugs standard control organization and state drugs standard control organization issue the drug license in India. Normally, the drug control organization issues two types DL, one is Retail drug license which is issued to a person who runs a chemist shop and another one is a Wholesale drug license which is issued to a person who wants to sell drugs on a wholesale level. In some states, retail drug license is issued only to that person who possesses the degree or diploma in Pharma from the recognized university.

At Vibcare Pharma, we do the billing on both Retail DL and wholesale DL.

Q12. What is NEFT/ IMPS/ Cheque / Demand Draft?

NEFT – It stands for National Electronic Funds Transfer. It is a nation-wide payment system facilitating one-to-one funds transfer. Under this Scheme, individuals can electronically transfer funds from any bank branch to any individual having an account with any other bank branch in the country.

RTGS – It stands for Real Time Gross Settlement. It is an electronic form of funds transfer where the transmission takes place on a real time basis. In India, the transfer of funds with RTGS is done for the high-value transaction, the minimum amount being Rs 2 lakh. The beneficiary account receives the funds transferred, on a real time basis.

Demand Drafts – Demand Draft is a pre-paid Negotiable Instrument, wherein the drawee bank undertakes to make payment in full when the instrument is presented by the payee for payment. The demand draft is made payable on a specified branch of a bank at a specified Centre. So, in such cases, Demand draft is accepted where the transfer of money is guaranteed. Demand draft is valid for a period of 3 months.

Cheque – It is a document that orders a bank to pay a specific amount of money from a person's account to the person in whose name the cheque has been issued it is issued by an individual. Cheque may be written only by an account holder. Cheque can be dishonored due to insufficient balance. But it may take 3-4 days to transfer the amount by cheque.

Q13. What is third-party manufacturing?

Third party or contract manufacturing is referred to the outsourcing of pharmaceutical products or to get products manufactured from other manufacturing units with your own brand names.

Start Third Party Manufacturing Business

Q14. How many products do we have at Vibcare Pharma and how many divisions with Therapeutic Segments?

We at the Vibcare are dealing in Six Main Divisions namely with more than 700 products in our portfolio.

Vibcare Pharma Divisions

Prima (General division)
Auspin (General division)
Cure (Cardio Diabetic)
Grace (Derma)
Mind (Neuropsychiatry)
Optho (Ophthalmic)

Q15. What is credit? what is Vibcare Pharma’s credit policy?

Credit means receiving something of value now and promising to pay for it later, often with a finance charge added by the lender. Vibcare pharma’s credit policy is that no credit selling and if there is any credit selling then the customer needs to provide Bank Guarantee against the credit amount.

Q16. What is the full form of PI and what is its meaning? What is the difference between PI and Tax invoice?

PI - The full form of PI is pro forma Invoice. A pro forma invoice is a preliminary bill of sale sent to buyers in advance of a shipment or delivery of goods. The invoice will typically describe the purchased items and other important information such as the rates, MRP, Batch number and expiry. PI is not valid for Input Tax.

Tax invoice - A commercial instrument delivered to the buyer containing the details of products or services provided by the seller is known as an invoice. Tax Invoice is valid for Input Tax.

Q17. List all promotional materials provided by Vibcare Pharma.

The promotional materials which are being provided by Vibcare Pharma are as follows:

Cotton Shirt with Vibcare Logo
MR Bag with Vibcare Logo
Water bottle
Brochure
Catch covers
Key chains
Order book
Table calendar
Visual Aid
Prescription pads
LBL
Pens
Paperweight
Diary
Trail Pack
Visiting card

Q18. What is monopoly Right?

The monopoly means the only supplier of a particular commodity in a particular area. In a monopoly, a single person or entity controls the market. A Pharma Franchise monopoly agreement means one person or company at one location as said in the agreement. If you want to have the monopoly right then it is best to look for the vacancy in the particular location you are looking for.

Q19. What is the sales tax?

A sales tax is a tax paid to a governing body for the sales of certain goods and services. Sales tax is levied on the sale of goods and services which have been produced or imported. If the same goods and services are re-sold without any value addition, then sales tax is not levied again. Sales tax is levied under the authority of both Central government as well as state governments.

Q20. What is WHO and GMP?

The World Health Organization (WHO) is a specialized agency of the United Nations that is concerned with international public health. WHO system ensures that products are produced and controlled according to the WHO quality standards. More strictness is followed in WHO manufacturing process than GMP.

A GMP is a system for ensuring that products are consistently produced and controlled according to quality standards. GMP covers all aspects of production from the starting materials, premises, and equipment to the training and personal hygiene of staff. There must be systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process - every time a product is made.

WHO-GMP certificates are of great value. These certificates show that the company’s quality is maintained in each department (in case of GMP certificate) and is also producing formulations, which are of international quality standards (in case of WHO GMP certificate).

Q21. What is the difference between ethical, PCD and generic medicines?

Generic medicines are the same as compare to ethical medicines in all aspects i.e. strength, dosage, efficacy, results, uses, etc. but it is cheap in price as compared to branded or ethical products. Same is the case with PCD franchise medicine; the same medicine is used as in case of generic and ethical. The only difference is the channel of distribution. We cannot say which medicine is better, medicine is the same, the manufacturing process is the same, and raw material origin is the same. The difference is created by the marketing team.

Best Digestive Enzyme Syrup in India

Digestive Enzyme Syrup

Digestive Enzyme Syrup is used when the pancreas cannot make or does not release enough digestive enzymes into the gut to digest the food.

Digestive Enzyme Syrup made up of digestive enzymes which are natural elements. These natural elements are needed by the human body to help digest food.

What is Enzyme?

Enzymes are complex proteins that cause a specific chemical change in all parts of the body. For example, they can help break down the foods we eat so the body can use them. Blood clotting is another example of enzymes at work.

Enzymes are needed for all the human body functions. Enzymes are found in every organ and cell in the body including:

Blood
Intestinal fluids
Mouth
Stomach

Types of Enzymes

Oxidoreductases
Transferases
Hydrolases
Lyases
Isomerases
Ligases

How to export medicines from India to other countries

Pharmaceutical Medicines Exports From India

The Indian pharmaceuticals industry is the third-largest in terms of volume and thirteenth-largest in terms of value. It has established itself as a global manufacturing and research hub. The Indian pharmaceutical industry is expected to grow at a compound annual growth rate (CAGR) of 22.4 percent to touch US 55 billion dollars by 2020.

The Indian Pharmaceutical market is dominated by generic drugs which constitute nearly 70 percent of the market, whereas Over the Counter medicines and patented drugs make up to twenty-one percent and nine percent respectively.

PHARMACEUTICAL EXPORTS AND ADVANTAGE INDIA

Pharmaceutical export from India stood at US$ 17.27 billion in 2017-18 and is expected to grow by 30 percent to reach the US $20 billion by the year 2020.
Exports of pharmaceutical products together stood at US$ 10.80 billion during April-October 2018.
During April-October 2018, top importers of India’s pharmaceutical products were USA ( US$ 3.21 billion), UK (US$ 383.30 million), South Africa (US$ 367.35 million), Russia (US$ 283.33 million) and Nigeria (US$ 255.89 million).
India is expected to rank amongst the top three pharmaceutical markets in terms of incremental growth by 2020.
India is the largest supplier of generic medicines globally (20 to 22 percent of global export volume)
India has one of the lowest manufacturing costs in the world. It is lower than that of the USA and almost half of Europe.

Procedure To Export Medicines From India

If you are a registered pharmaceutical company in India then there is an easy process to export medicines from India.

The first step is to apply for the IEC (Import Export Code) number.
Contact the exporters of other countries who are interested in importing the medicines.
Register your product in the country you are going to export.
Get the approval for export from DCGI (Drug Controller General of India).
Finalize the shipping method or choose the trader, exporter, supplier of pharmaceutical products.
Receive the Purchase Order from the company which is importing the medicines from India and send a proforma invoice with product details like type of packing, the rate of the product, freight details, etc.
Prepare commercial invoice against Letter of Credit or Purchase Order.
Sign contract with the freight forwarding agency to ship the material to the respective country.
After completing all the documentation, you need to move to customs clearance.
After getting clearance, the pharmaceutical products will be shipped to the importing country.
Customs clearance is required in the importing country too.

How to Apply for IEC to Export Medicines from India

Procedure to apply for IEC Number

Step 1: Go to the official website of Directorate General of Foreign Trade

Step 2: Click on the ‘Online Application’ tab and select the ‘IEC’ from the drop-down menu.
Step 3: Then choose ‘Online IEC Application’
Step 4: Enter your PAN number to log in and click on Next button.
Step 5: Go to File and choose ‘New IEC Application details’
Step 6: Then a form will appear. Fill all the details in the form and click on ‘Upload Documents’
Step 7: Upload the required documents.
Step 8: After uploading the documents and filling the form, click on the ‘Branch’ button to add any branch details.
Step 9: Then click on ‘Director’ to add the details of the directors.
Step 10: Then click on ‘EFT’ to make an online payment.
Step 11: Fill the amount details, which is Rs. 250 and choose your bank to make a transaction.
Step 12: Then a draft invoice will appear. Check all the filled details and click on ‘Pay now’ button.
Step 13: Make the payment by using your internet banking details.

Mandatory Requirements to apply for IEC Number

PAN Number
Current Bank Account
Bankers Certificate
IEC Code Number Application Fee
The hard copy of application containing required documents should reach DGFT RLA concerned within 15 days of its online submission.

China also showing interest in importing medicines from India

Latest DPCO Price List

[vc_row][vc_column][ultimate_heading main_heading="Latest DPCO Price List by the Government"][/ultimate_heading][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_column_text][pdf-embedder url="https://vibcare.co.in/wp-content/uploads/2019/03/dpco-price-list-nov-2018-01.pdf" title="dpco price list nov 2018 01"][/vc_column_text][/vc_column][vc_column width="1/2"][vc_column_text][pdf-embedder url="https://vibcare.co.in/wp-content/uploads/2019/03/dpco-price-list-nov-2018-02.pdf" title="dpco price list nov 2018 02"][vc_row][vc_column width="1/2"][vc_column_text][pdf-embedder url="https://vibcare.co.in/wp-content/uploads/2019/03/dpco-price-list-nov-2018-03.pdf" title="dpco price list nov 2018 03"][/vc_column_text][/vc_column][vc_column width="1/2"][vc_column_text][pdf-embedder url="https://vibcare.co.in/wp-content/uploads/2019/03/dpco-price-list-nov-2018-04.pdf" title="dpco price list nov 2018 04"][pdf-embedder url="https://vibcare.co.in/wp-content/uploads/2019/03/dpco-price-list-nov-2018-05.pdf" title="dpco price list nov 2018 05"]2nd November 2018

ORDER

S.O. 5633(E) In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S.O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the prices as specified in column (5) of the table hereinbelow as ceiling price exclusive of goods and services tax applicable, if any, in respect of the Scheduled formulations specified in the corresponding entry in column

(2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

TABLE

Sl. No.	Name of the Scheduled Formulation	Dosage form & Strength	Unit	Ceiling Price (Rs.)
(1)	(2)	(3)	(4)	(5)
1.	Dimercaprol	Injection 50 mg/ml	1 ml	187.85
2.	Phytomenadione (Vitamin K1)	Tablet 10mg	1 Tablet	13.63
3.	Paracetamol	Oral Liquid 100 mg/ml (pediatric)	1 ml	1.52

Note:

All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if
All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO,
The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said
The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and
As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the
Where an existing manufacturer of a scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing

the manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.

The manufacturers of above said scheduled formulations shall furnish a quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of
The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act,
Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s)

2nd November 2018

ORDER

S.O. 5634(E) In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 1462(E), dated 2nd April 2018, in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the prices as specified in column (5) of the table herein below as ceiling price exclusive of goods and services tax applicable, if any, in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

TABLE

Sl. No.	Name of the Scheduled Formulation	Dosage form & Strength	Unit	Ceiling Price (Rs.)
(1)	(2)	(3)	(4)	(5)
1.	Nitrous oxide	Inhalation	Cubic meter	219.29
2.	Oxygen	Inhalation (Medicinal gas)	Cubic Meter	16.47

Note:

All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if
All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO,
The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said
The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and
As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the
Where an existing manufacturer of a scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing

the manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.

The manufacturers of above said scheduled formulations shall furnish a quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of
The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act,
Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s)

2nd November 2018

ORDER

O. 5635(E) In implementation of directions given in line with review orders issued by the Department of Pharmaceuticals (DOP) vide order(s) specified in column (6) of the table hereinbelow passed by the Department of Pharmaceuticals under para 31 of Drugs (Prices Control) Order, 2013 and In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) specified in the Column

of the table, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (5) of the table hereinbelow as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company , as specified in the corresponding entries in columns (3), (4) and (8) thereof;

Table

Sl. No.	Name of the Formulation	Dosage form & Strength	Unit	Retail Price (Rs.)	Review Order number and date	Existing SO number & date	Manufacturer & Marketing Company respectively
(1)	(2)	(3)	(4)	(5)	(6)	(7)	(8)
1.	Ramipril + Amlodipine Tablet	Each uncoated tablet contains: Ramipril IP 5mg Amlodipine Besylate IP eq. to Amlodipine 5mg	1 Tablet	12.04	31015/2/2018- Pricing dated 08.6.2018	3915(E) dated 18.12.2017 (at Sl. No. 12)	M/s Lupin Limited
2.	Ferrous Ascorbate + Folic Acid + Cyanocobalamin + Zinc Sulphate Monohydrate tablet (Autrin- XT)	Each film coated tablet contains: Ferrous Ascorbate eq. to Elemental Iron 100mg, Folic Acid IP 1.5mg, Cyanocobalamin IP 15 mcg, Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 22.5mg	1 Tablet	8.01	31015/8/2018- Pricing dated 22.06.2018	3915(E) dated 18.12.2017 (at Sl. No. 1)	M/s Tirupati Medicare Limited / M/s Pfizer Limited
3.	Amlodipine + Valsartan Tablet (Valembic 80 AM)	Each film coated tablet contains: Amlodipine Besylate eq. to Amlodipine USP 5mg, Valsartan USP 80mg	1 Tablet	5.56	31015/25/2018- Pricing dated 06.08.2018	793(E) dated 23.02.2018 (at Sl. No. 1)	M/s Vapicare pharma Pvt. Ltd. / M/s Alembic Pharmaceuticals Limited
4.	Amlodipine + Valsartan Tablet (Valembic 160 AM)	Each film coated tablet contains: Amlodipine Besylate eq. to Amlodipine USP 5mg, Valsartan USP 160mg	1 Tablet	8.56	31015/25/2018- Pricing dated 06.08.2018	793(E) dated 23.02.2018 (at Sl. No. 2)	M/s Vapicare pharma Pvt. Ltd. / M/s Alembic Pharmaceuticals Limited
5.	Olmesartan + Amlodipine + Chlorthalidone Tablet (Triolmezest CH 20)	Each film coated tablet contains: Olmesartan IP 20mg Amlodipine Besylate IP eq. to Amlodipine 5mg Chlorthalidone IP – 12.5mg	1 Tablet	9.15	31015/37/2018- Pricing dated 04.09.2018	2398(E) dated 12.6.2018 (at Sl. No. 10)	M/s Synokem Pharmaceuticals Ltd. / M/s Sun Pharma Laboratories Ltd.
6.	Olmesartan +	Each film coated tablet	1	16.19	31015/37/2018-	2398(E)	M/s Synokem

	Amlodipine + Chlorthalidone Tablet (Triolmezest CH 40)	contains: Olmesartan IP 40mg Amlodipine Besylate IP eq. to Amlodipine 5mg Chlorthalidone IP – 12.5mg	Tablet		Pricing dated 04.09.2018	dated 12.6.2018 (at Sl. No. 11)	Pharmaceuticals Ltd. / M/s Sun Pharma Laboratories Ltd.
7.	Rosuvastatin +	Each film coated tablet	1	11.43	31015/37/2018-	2398(E)	M/s Pure and Cure
	Clopidogrel	contains:	Tablet		Pricing dated	dated	Healthcare Pvt. Ltd.
	Tablet (ROSUVAS	Rosuvastatin Calcium IP eq.			04.09.2018	12.6.2018	/ M/s Sun
	CV 10)	to Rosuvastatin 10mg,				(at Sl. No. 9)	Pharmaceutical
		Clopidogrel Bisulfate IP eq.					Industries Ltd
		to Clopidogrel 75mg

Note:

The manufacturer of above-mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table
The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said
The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and
As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the
The above mentioned retail prices are applicable only to the manufacturer / marketer as mentioned above for generic / any brand of the same composition / strength of the subject formulations, subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturers/marketing companies.
In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act,

2nd November 2018

ORDER

S.O. 5636(E) In implementation of directions given in line with review orders issued by the Department of Pharmaceuticals (DOP) vide order(s) specified in column (6) of the table hereinbelow passed by the Department of Pharmaceuticals under para 31 of Drugs (Prices Control) Order, 2013 and in exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S.O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) specified in the Column (7) of the table regarding formulation specified in mentioned in the table in so far as it relates to formulation pack mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby fixes/revises the price as specified in column (5) of the table hereinbelow as ceiling price exclusive of goods and services tax applicable, if any, in respect of the Scheduled formulation(s) specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

TABLE

Sl. No.	Name of the Scheduled Formulation	Dosage form & Strength	Unit	Ceiling Price (Rs.)	Review Order number and date	Existing SO number and date
(1)	(2)	(3)	(4)	(5)	(6)	(7)
1.	Anti-Tetanus	250IU	Each Pack	1043.05	31015/29/2017-PI.I	1461(E) dated
	Immunoglobulin				dated 6.8.2018	2.04.2018
						(at Sl. No. 60)
						Read with
						corrigendum SO
						2400(E) dated
						12.6.2018

Note:

All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if
All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO,
The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said
The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and

As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the
Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO,
The manufacturers of above said scheduled formulations shall furnish a quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of
The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act,
Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s)

2nd November 2018

ORDER

O. 5638(E) In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O. 701(E) dated 10th March 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table hereinbelow as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Table

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1.	Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet	Each uncoated bilayer tablet contains: Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20 mg Metformin Hydrochloride IP 1000 mg (SR)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Anthem Biopharma Pvt. Ltd.	10.23
2.	Metformin HCL + Glimepiride Tablet (Semi Amaryl M)	Each uncoated bilayer tablet contains: Metformin Hydrochloride IP (in prolonged release form) 500 mg Glimepiride IP 0.5 mg	1 Tablet	M/s Windlass Biotech Pvt. Ltd. / M/s Sanofi India Ltd.	3.77
3.	Telmisartan + Cilnidipine + Chlorthalidone tablet	Each film coated tablet contains: Telmisartan IP 40 mg Chlorthalidone IP 6.25 mg Cilnidipine IP 10 mg	1 Tablet	M/s Windlass Biotech Pvt. Ltd / M/s Abbott Healthcare Pvt. Ltd	10.31
4.	Clarithromycin for Oral Suspension	Each 5ml (after reconstitution) contains: Clarithromycin IP 250mg, Titanium Dioxide IP (-).	1 ML	M/s Cipla Limited	5.49
5.	Telmisartan + Amlodipine + Chlorthalidone Tablet (Telmelife 3D)	Each film coated tablet contains: Telmisartan IP 40 mg Amlodipine Besylate IP eq. to Amlodipine 5 mg Chlorthalidone IP 12.5 mg	1 Tablet	M/s Akums Drugs & pharmaceuticals Ltd / M/s Neomac Pharmaceuticals Pvt. Ltd	8.91
6.	Atorvastatin + Clopidogrel Capsule	Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin (As film coated tablet) 20 mg Clopidogrel Bisulphate IP eq. to Clopidogrel (as two film coated tablet each containing 37.5mg) 75 mg	1 Capsule	M/s Windlas Biotech Ltd. / M/s Abbott Healthcare Pvt. Ltd.	9.50
7.	Amoxycillin + Potassium Clavulante	Each uncoated dispersible tablet contains:	1 Tablet	M/s Saitech Medicare Pvt. Ltd. / M/s Galpha	7.45

	tablet (Clanoxy DT)	Amoxycillin Trihydrate eq. to Amoxycillin 200mg Potassium Clavulante Diluted IP eq. to Clavulanic Acid 28.5mg		Laboratories Ltd.
8.	Tramadol + Paracetamol Tablet (Trson-P)	Each film coated tablet contains: Tramadol Hydrochloride IP 37.5 mg Paracetamol IP 325 mg	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	2.49
9.	Voglibose + Metformin Tablet (Voglyson-M 0.3)	Each uncoated bilayered tablet contains: Voglibose IP 0.3 mg Metformin Hydrochloride IP 500 mg (as sustained release form)	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	3.86
10.	Rosuvastatin + Aspirin + Clopidogrel Capsules	Each hard gelatin capsules contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 10 mg (as pellets) Aspirin IP 75 mg (as enteric coated pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (as pellets)	1 Capsule	M/s Synokem Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd.	11.62
11.	Mycophenolate Mofetil Oral Suspension IP	Each 5 ml of reconstituted suspension contains: Mycophenolate Mofetil IP 1 g, (1 bottle with 110gm powder for oral suspension containing 35gm Mycophenolate Mofetil)	Each Pack	M/s Panacea Biotec Ltd.	5238.09
12.	Bisacodyl Suppository	Each Suppository contains: Bisacodyl IP 10 mg	1 Suppository	M/s Meridian Enterprises Pvt. Ltd.	18.63
13.	Telmisartan + Chlorthalidone Tablet (Telmelife CH 40)	Each film coated tablet contains: Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg	1 Tablet	M/s Akum Drugs & Pharmaceuticals Ltd. / M/s Neomac Pharmaceuticals Pvt. Ltd.	8.00
14.	Cilnidipine + Telmisartan Tablet	Each film coated tablet contains: Telmisartan IP 80 mg Cilnidipine 10 mg	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd.	10.60
15.	Divalproex Tablet (Diwok OD 750 mg)	Each film coated extended release tablet contains: Divalproex Sodium IP eq. to Valproic Acid 750 mg	1 Tablet	M/s Swiss Garnier Biotech / M/s Wockhardt Ltd.	11.24
16.	Clotrimazole + Beclomethasone Dipropionate Cream	Cream contains: Clotrimazole IP 1.00% w/w Beclomethasone Dipropionate IP 0.025% w/w	1 GM	M/s Curetech Skincare / M/s Mankind Pharma Ltd.	4.46
17.	Telmisartan + Chlorthalidone Tablet (Cresar CT)	Each uncoated bilayered tablet contains: Telmisartan IP 40 mg Chlorthalidone IP 6.25 mg	1 Tablet	M/s Acme Formulations Pvt. Ltd. / M/s Cipla Ltd.	7.71
18.	Baclofen Oral Solution	Each 5 ml contains: Baclofen IP 5 mg	1 ML	M/s Sun Pharmaceutical Industries Ltd. / M/s Sun Pharma Laboratories Ltd.	1.42
19.	Glimepiride + Metformin Hydrochoride Tablet	Each uncoated bilayered tablet contains: Metformin Hydrochoride IP (as prolonged release) 500 mg Glimepiride IP 3 mg	1 Tablet	M/s Sun Pharma Laboratories Ltd.	6.99
20	Glimepiride + Metformin Hydrochoride Tablet	Each uncoated bilayered tablet contains: Metformin Hydrochoride IP (as prolonged release) 500 mg Glimepiride IP 4 mg	1 Tablet	M/s Sun Pharma Laboratories Ltd.	8.58

21.	Glimepiride + Metformin Hydrochoride Tablet	Each uncoated bilayered tablet contains: Metformin Hydrochoride IP (as prolonged release) 1000mg Glimepiride IP 4 mg	1 Tablet	M/s Sun Pharma Laboratories Ltd.	9.78
22.	Metformin HCL + Gliclazide + Pioglitazone Tablets	Each uncoated bilayered tablet contains: Metformin Hydrochoride IP (sustained release) 500 mg Gliclazide IP (sustained release) 30 mg Pioglitazone HCL eq. to Pioglitazone 15 mg	1 Tablet	M/s Eris Lifesciences Ltd.	5.78
23.	Metformin HCL + Gliclazide + Pioglitazone Tablets	Each uncoated bilayered tablet contains: Metformin Hydrochoride IP (sustained release) 500 mg Gliclazide IP (sustained release) 60 mg Pioglitazone HCL eq. to Pioglitazone 15 mg	1 Tablet	M/s Eris Lifesciences Ltd.	8.29
24.	Chlorthalidone + Telmisartan Tablet (Telsar CH 40/6.25)	Each film coated tablet contains: Chlorthalidone IP 6.25 mg Telmisartan IP 40 mg	1 Tablet	M/s Gkm New Pharma / M/s Torrent Pharmaceuticals Ltd.	7.71
25.	Chlorthalidone + Telmisartan Tablet (Telsar CH 40/12.5)	Each film coated tablet contains: Chlorthalidone IP 12.5mg Telmisartan IP 40 mg	1 Tablet	M/s Gkm New Pharma / M/s Torrent Pharmaceuticals Ltd.	8.03
26.	Chlorthalidone + Telmisartan Tablet (Telsar CH 80/12.5)	Each film coated tablet contains: Chlorthalidone IP 12.5mg Telmisartan IP 80 mg	1 Tablet	M/s Gkm New Pharma / M/s Torrent Pharmaceuticals Ltd.	13.91
27.	Divalproex Tablet (Diwok OD 250 mg)	Each film coated extended release tablet contains: Divalproex Sodium IP eq. to Valproic Acid 250 mg	1 Tablet	M/s Swiss Garnier Biotech / M/s Wockhardt Ltd.	5.45
28.	Voglibose + Metformin tablet	Each uncoated tablet contains: Voglibose IP 0.2 mg Metformin HCL IP 500 mg	1 Tablet	M/s Eris Lifesciences Ltd.	6.57
29.	Amoxycillin + Potassium Clavulnate Dry Syrup (Blumox-CA Forte)	Each combipack containing: a) Amoxycillin and Potassium Clavulanate Oral Suspension IP Each 5 ml suspension containing Amoxycillin Trihydrate IP eq. to Amoxycillin 400 mg Potassium Clavulnate diluted IP eq. to Clavulanic Acid 57 mg b) 1 vial sterile water for injection IP Each vial containing Sterile water for injection IP 30 ml	1 ML	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Blue Cross Laboratories Pvt. Ltd.	3.16
30.	Rosuvastatin + Aspirin + Clopidogrel Capsule	Each hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20 mg (as pellets) Aspirin IP 75 mg (as enteric coated pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg (as pellets)	1 Capsule	M/s Synokem Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd.	17.88
31.	Rosuvastatin + Aspirin + Clopidogrel	Each hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg (as pellets)	1 Capsule	M/s Synokem Pharmaceuticals Ltd. / M/s Emcure	11.62

	Capsule	Aspirin IP 75mg (as enteric coated pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (as pellets)		Pharmaceuticals Ltd.
32.	Diclofenac + Virgin Linseed Oil + Methyl Salicylate + Menthol + Capsaicin Gel (Diclofam Hot)	Gel containing Diclofenac Diethylamine BP 1.16% w/w (eq. to Diclofenac Sodium 1% w/w) Virgin linseed Oil BP 3% w/w (containing predominantly Alpha Linolenic Acid) Methyl Salicylate IP 10% w/w Menthol IP 5% Capsaicin USP 0.0255w/w, Benzyl Alcohol IP 1%w/w	1 GM	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.	2.41
33.	Clotrimazole + Lignocaine Ear Drops (Triben)	Ear drops contains: Clotrimazole IP 1.0% w/v Lignocaine Hydrochloride IP 2.0% w/v	1 ML	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Jenburkt Pharmaceuticals Ltd.	5.27
34.	Timolol + Brinzolamide Eye Drops	Each ml contains Brinzolamide IP 1.0 w/v Timolol Maleate IP eq. to Timolol 0.5% w/v, Benzalkonium Chloride IP 0.01% w/v (as preservative)	5ML	M/s Ajanta Pharma Ltd.	283.25
35.	Diclofenac + Methyl + Menthol GEL (Volini Maxx Gel)	Contains: Diclofenac Diethylamine BP 2.32% w/w (eq. to Diclofenac Sodium 2% w/w), Methyl Salcylate IP 10% w/w & Menthol IP 5% w/w	Each Pack (20 gram)	M/s Sun Pharmaceutical Industries Ltd.	125.00
36.	Diclofenac + Methyl + Menthol GEL (Volini Maxx Gel)	Contains: Diclofenac Diethylamine BP 2.32% w/w (eq. to Diclofenac Sodium 2% w/w), Methyl Salcylate IP 10% w/w & Menthol IP 5% w/w	Each Pack (30 gram)	M/s Sun Pharmaceutical Industries Ltd.	187.50
37.	Olmesartan + Amlodipine + Chlorthalidone Tablet (TRIOLSAR 20)	Each film coated tablet contains: Olmesartan Medoxomil 20mg, Chlorthalidone IP 6.25mg, Amlodipine Besylate IP eq. to Amlodipine 5mg tablets	1 Tablet	M/s GKM New Pharma Ltd. / M/s Unichem Laboratories Limited	9.585
38.	Olmesartan + Amlodipine + Chlorthalidone Tablet (TRIOLSAR 40)	Each film coated tablet contains: Olmesartan Medoxomil 40mg, Chlorthalidone IP 6.25mg, Amlodipine Besylate IP eq. to Amlodipine 5mg tablets	1 Tablet	M/s GKM New Pharma Ltd. / M/s Unichem Laboratories Limited	15.61

39.	Losartan + Chlorthalidone + Amlodipine Tablet (TRILOSAR 6.25 )	Each film coated tablet contains: Losartan Potassium IP 50mg, Chlorthalidone IP 6.25mg, Amlodipine Besylate IP eq. to Amlodipine 5mg tablets	1 Tablet	M/s GKM New Pharma Ltd. / M/s Unichem Laboratories Limited	6.36
40.	Losartan + Chlorthalidone + Amlodipine Tablet (TRILOSAR 12.50)	Each film coated tablet contains: Losartan Potassium IP 50mg, Chlorthalidone IP 12.50mg, Amlodipine Besylate IP eq. to Amlodipine 5mg tablets	1 Tablet	M/s GKM New Pharma Ltd. / M/s Unichem Laboratories Limited	6.41
41.	Darunavir + Ritonavir tablet	Each film coated tablet contains: Darunavir Ethanolate eq. to Darunavir 600mg and Ritonavir IP 100mg tablet	1 Tablet	M/s Emcure Pharmaceuticals Limited	172.52
42.	Telmisartan + Amlodipine + Chlorthalidone Tablet (Tazloc AC 12.5)	Each uncoated bilayered tablet contains: Telmisartan IP 40 mg Amlodipine Besylate IP eq. to Amlodipine 5 mg Chlorthalidone IP 12.5 mg	1 Tablet	M/s Aeon Formulations Pvt. Ltd. / M/s USV Pvt. Ltd.	8.91
43.	Darunavir + Ritonavir tablet (Durart – R 450)	Each film coated tablet Contains: Darunavir 400mg & Ritonavir 50mg Tablets	1 Tablet	M/s Mylan Laboratories Pvt. Ltd. / M/s Mylan Pharmaceuticals Pvt. Ltd.	123.71
44.	Diclofenac + Methyl + Menthol Salicylate + Menthol + Turpentine Oil Gel (Diclotal MR Gel)	Contains: Diclofenac Diethylamine BP 1.16%w/w (eq. to Diclofenac Sodium 1%), Methyl Salicylate IP 5% w/w, Mephenesin IP 85 5%w/w, Menthol IP 2% w/w, Turpentine Oil BP 3%w/w	1 GM	M/s The Madras Pharmaceuticals / M/s Blue Cross Laboratories Pvt. Ltd.	2.46
45.	Lamivudine + Tenofovir + Dolugetravir tablet	Each film coated tablet contains: Lamivudine IP 300mg, Tenofovir Disoproxil Fumarate IP 300mg eq. to Tenofovir Disoproxil 245mg, Dolugetravir Sodium eq. to Dolutegravir 50mg.	1 Tablet	M/s Emcure Pharmaceuticals Limited	114.06
46.	Darunavir + Ritonavir tablet (Danavir R)	Each film coated tablet contains: Darunavir Ethanolate eq. to Darunavir 800mg, Ritonavir 100mg Tablet	1 Tablet	M/s Hetero Labs Limited / M/s Hetero Healthcare Limited	212.91
47.	Lamivudine + Tenofovir + Dolugetravir tablet (ACRIPTEGA)	Each uncoated tablet contains: Lamivudine IP 300mg, Tenofovir Disoproxil Fumarate IP 300mg, Dolugetravir Sodium eq. to Dolutegravir 50mg.	1 Tablet	M/s Mylan Laboratories Limited / M/s Mylan Pharmaceuticals Private Limited	114.06

48.	Daclatasvir + Sofosbuvir tablet (HEPCINAT PLUS)	Each film coated tablet contains: Daclatasvir Dihydrochloride eq. to Daclatasvir 60mg, Sofosbuvir 400mg	1 Tablet	M/s Natco Pharma Limited	556.442
49.	Daclatasvir + Sofosbuvir tablet	Each film coated tablet contains: Daclatasvir Dihydrochloride eq. to Daclatasvir 60mg, Sofosbuvir 400mg	1 Tablet	M/s Natco Pharma Limited / M/s Cadila Healthcare Limited	556.442
50.	Daclatasvir + Sofosbuvir tablet (MYHEP DVIR)	Each film coated tablet contains: Daclatasvir Dihydrochloride eq. to Daclatasvir 60mg, Sofosbuvir 400mg	1 Tablet	M/s Mylan Laboratories Pvt. Ltd. / M/s Mylan Pharmaceuticals Pvt. Ltd.	556.442
51.	Diclofenac + Methyl + Menthol GEL (Volini Maxx Gel)	Contains: Diclofenac Diethylamine BP 2.32% w/w (eq. to Diclofenac Sodium 2% w/w), Methyl Salicylate IP 10% w/w & Menthol IP 5% w/w	Each Pack (15 gram)	M/s Sun Pharmaceutical Industries Ltd.	93.75
52.	Diclofenac + Methyl + Menthol GEL (Volini Maxx Gel)	Contains: Diclofenac Diethylamine BP 2.32% w/w (eq. to Diclofenac Sodium 2% w/w), Methyl Salcylate IP 10% w/w & Menthol IP 5% w/w	Each Pack (10 gram)	M/s Sun Pharmaceutical Industries Ltd.	62.50
53.	Ceftriaxone 1 gm plus Tazobactum 125 mg injection	Each injection vial contains: Ceftriaxone Sodium IP eq. to Ceftriaxone 1 gm Tazobactum Sodium eq. to Tazobactum 125 mg	1 Vial	M/s Innova Captab Pvt. Ltd. / M/s Emcure Pharmaceuticals Ltd	136.11
54.	Cefpodoxime + Potassium Dry Syrup (Cefoprox CV)	Each 5 ml of the reconstituted suspension contains: Cefpodoxime Proxetil IP eq. to Cefpodoxime 50 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 31.25 mg	1 ML	M/s Hetero Labs Ltd / M/s Cipla Limited	2.40
55.	Cefpodoxime + Potassium Dry Syrup (Cefoprox CV)	Each 5 ml of the reconstituted suspension contains: Cefpodoxime Proxetil IP eq. to Cefpodoxime 100 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 62.5mg	1 ML	M/s Hetero Labs Ltd / M/s Cipla Limited	3.72

Note:

The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table

The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said
The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and
As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the
The above mentioned retail price is applicable only to the individual manufacturer / marketeer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing
In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act,
Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s)

DPCO Price List - March 2019

DPCO PRICE LIST MARCH 2019

First PCD Pharma Company in Gujarat

INTAS PHARMACEUTICALS

Second PCD Pharma Company in Gujarat

TORRENT PHARMACEUTICALS

Third PCD Pharma Company in Gujarat

CADILA PHARMACEUTICALS

Fourth PCD Pharma Company in Gujarat

ERIS LIFESCIENCES LIMITED

Fifth PCD Pharma Company in Gujarat

TROIKAA PHARMACEUTICALS LIMITED

Q1. What is pharma franchise?

Q2. What is PCD Pharma and what is its full form?

Q3. Is PCD Pharma different from Pharma Franchise?

Q4. Is CD (Cash Discount) better or scheme better for the customer?

Q5. What are the different modes of transportation of goods?

Q6. What is GR/LR/Bilty?

Q7. What is Draft on Delivery (DOD)? Which transports provide this facility?

Following are some of the transporters which provide the facility of DOD:

TCI Express

TCI Freight

VRL

Gati

Safe express

Q8. What is Account Ledger and how can you receive payment from a customer?

Following are the means by which payments can be received:

IMPS

RTGS

NEFT

Cash Deposit

Demand Draft (DOD)

Q9. What is PTR, PTS and what are the percentages of PTR, PTS (Including GST)?

Q10. What is GST?

Q11. What is a drug license? What types of Drug License are important for us at Vibcare Pharma?

Q12. What is NEFT/ IMPS/ Cheque / Demand Draft?

Q13. What is third-party manufacturing?

Q14. How many products do we have at Vibcare Pharma and how many divisions with Therapeutic Segments?

Q15. What is credit? what is Vibcare Pharma’s credit policy?

Q16. What is the full form of PI and what is its meaning? What is the difference between PI and Tax invoice?

Q17. List all promotional materials provided by Vibcare Pharma.

Q18. What is monopoly Right?

Q19. What is the sales tax?

Q20. What is WHO and GMP?

Q21. What is the difference between ethical, PCD and generic medicines?

Digestive Enzyme Syrup

What is Enzyme?

Types of Enzymes

Pharmaceutical Medicines Exports From India

PHARMACEUTICAL EXPORTS AND ADVANTAGE INDIA

Procedure To Export Medicines From India

How to Apply for IEC to Export Medicines from India

ORDER

TABLE

ORDER

TABLE

ORDER

Table

ORDER

TABLE